୯ҥᆵεᏢғނၗྍᄤၭᏢଣ१ࠔࣽמࣴز܌
ᅺγፕЎ
Graduate Institute of Food Science and Technology College of Bioresources and Agriculture
National Taiwan University Master Thesis
аଯਏૈϩηᑔቫݤᆶሇનೱ่խࣝϩݤ ϩՋࢩୖНྋ܄όёϯӭᗐϐϩη่ᄬቻ
Fingerprinting water-soluble nondigestible polysaccharides of Panax quinquefolius by high performance size exclusion
chromatography combined with enzyme-linked immunosorbent assay.
Ц၃൛
Shih-Ting, Wang
ࡰᏤ௲Ǻֈዞ റγ Advisor: Ting-Jang Lu, Ph. D.
ύ҇୯ 102 ԃ 7 Д
July, 2013
ᖴ ᖴᇞ
! ! གᖴৱৣ ֈዞറγӧ೭ٿԃύǴܭჴᡍǵፐϷғࢲޑࡰᏤᆶᜢЈǴ٬
ᏢғૈӵයֹԋፕЎǴӧ೭ϐύᏢಞډԴৣჴ٣ࢂޑᄊࡋϷλЈᙣޑᆒઓǴჹ ԴৣޑགᖴޑόࢂΟقٿᇟёаޑǶ
! ! ፕЎ߃ዺ܍ᆾ ύዼᜪ१ࠔπࣴز܌܌ߏ ᐽ૽ԴৣǵᓉەεᏢ१ࠔᔼᎦ Ꮲس ҉کԴৣǵьϏ░Ԗज़ϦљՉߏ ᒘስᑢ ԴৣϷەើεᏢ१ࠔࣽᏢس ᓛᒴૈԴৣჹҁፕЎޑቩǴඁᆶޑཀـᆶࡰ҅Ǵ٬ҁፕЎ׳ᑪֹऍǴӧԜు
߄གᐟǶ
! ! ٿԃޑᅺγғࢲ๊ჹόࢂҗԾρёаᐱԾֹԋǴሡाགᖴߚதӭΓޑᔅշǶག ᖴ ᖴలृԴৣǴӧྗഢࣴز܌Ե၂ය໔ǴှเፐޑୢᚒǴаϷӧჴᡍ๏ϒ ޑၗྍڐշǴനख़ाޑࢂᖴԴৣ๏ךޑႴᓰǴޔࢂךޑΚǶჴᡍ࠻ޑεৎǴ ᖴᖴգॺޑхǴᖴᖴដᏢۆߚதԖऐЈޑ௲ךჴᡍǴှ،ჴᡍ֚ᜤǴӵ݀ؒԖ یǴፕЎۓό೭ሶճǹᖴᖴဂඁᏢۆǴӧیيᏢډΑ໒ਟᢀޑғࢲᄊࡋǴ ߥ೭ኬޑߞۺǴ٣൩߆έԶှǹᖴᖴഓ൛ᏢۆǴӧჴᡍޑࡰᏤϷᡍޑϩ ٦Ǵی٣ޑᇡᆶߚதзΓ൧ལǹᖴᖴባᏢۆϷຽࢋᏢۆǴԖیॺޑࡰᏤ Ϸᔅշ٬ჴᡍճளӭǹᖴᖴऎ఼ᏢۆᔅךՉಒझჴᡍǴᗨฅࡕٰኧᏵؒԖҔǴ ᗋࢂߚதགᖴی܌ޑਔ໔ᆶЈΚǹᖴᖴഩฐᏢۆǴیᇡޑᄊࡋޑࡐзΓལٵǴ གᖴیሦךჴᡍǴޑࢂڙؼӭǹᖴᖴמӼᏢߏǴգଓფགྷޑᆒઓࡐॶள ךॺᏢಞǹᖴᖴႳϡᏢߏǴόӭ၉ޑգᕴࢂᓨᓨࣁჴᡍ࠻٣ǴჹፕЎޑाϷո ΚǴΨࢂךॺԖҞӅ࿏ޑǹᖴᖴଆѺܣޑუՔ⍌ᆶз݇Ǵό᚛ဌ፯ًޑך
ाམգॺޑߡًѐፐǴவᅺঅፐډᅺΒჴᡍޑВηǴԖգॺޑഉՔᡣ೭٤ ਔӀόېൂǹᖴᖴǴԛၟیಠϺளډࡐεޑ҅य़ૈໆǹᖴᖴࢅےǴЎਜλ ЦηޑЎਜמೌჴӧࢂӭளзΓᡋᡦǴߚதᖴᖴգޑᔅԆǹᖴᖴਁӹӧ GC-MS ௲ ػ૽ግޑбрǴჹܭ٣ޑոΚᄊࡋᡣգԏᛘࡐӭޑǹᖴᖴᜩཁǴԖیӧǴऍ१ ൩ό໔ᘐǴགᖴی๏ჴᡍ࠻Ϸ୍ޑٌधǹᖴᖴϘ࣓ᔅך࣮मЎᄔाа
Ϸࣁךॺٰࡓᇯޑऍ१ᆶЎϯǶନԜϐѦǴགᖴԢৎᆶጯৎॷрჴᡍᏔǴ٬
ჴᡍᏹբ׳БߡǶᖴᖴλۆǵڬλۆǵഋλۆϷڬӃғჹܭ१ࣽ܌ՉࡹϷᕴ୍٣
୍ޑбрᆶٌधǴӭᖝԖգॺω٬ள܌ޑၮբֹǶ
! ! ᖴᖴܻ϶ॺӧЈᡫᆶᆒઓ䶒ךޑႴᓰǴᖴᖴ Oscar Lin ޔӧךيᜐǴᖴᖴ G.j.Chen ࢂ҉ᇻޑคᆶউКޑऍǴᖴᖴۏଈǵጰோҦǵڬίǴգॺഉךوၸ ೭ࢤǴᖴᖴછ࿌ଈޑऍӳǴᖴᖴඵӹǵߪ◖کڑۗ㚎ǴգॺࢂךΓғύࡐ ख़ाޑܻ϶Ƕ
! ! ᙣаԜፕЎ๏നᒃངᆶЍךޑৎΓǴᖴᖴݿݿǵ༰༰ǵۂۂჹךޑᜢЈǴ գॺޑᎦػϐৱаϷЈਭ൩ӧޑךǹᖴᖴᚲނऔऔǵԺΤǵᓉॣᆶλǴ ёངޑգॺᡣྠඊѨόـǴനࡕǴᖴᖴޔؒԖܫకޑԾρǶ
၃൛ ᙣᇞ ୯ҥѠεᏢ १ࠔࣽמࣴز܌
ύ҇୯ 102 ԃ 7 Д
ᄔ ᄔा
! ! ൂਲ਼לᡏςදၹ٬Ҕܭࣴزނಒझ่ᄬǶҁፕЎᔕаሇનНှǵᚆηᐋિ
ቫǵଯਏૈϩηᑔቫݤ (high performance size excluion chromatography, HPSEC) ᆶሇનೱ่խࣝϩݤ (enzyme-linked immunosorbent assay, ELISA) ϩՋࢩୖ
Нྋ܄όёϯӭᗐϐϩη่ᄬቻǶஒѐନೈқ፦ޑՋࢩୖಉӭᗐǴаሇનНှ
ନѐᐘણǴளډНྋ܄όёϯӭᗐǴаᚆηҬඤᐋિቫسǴ٩ࢬࢱᡶᐚࡋ ϩᚆࣁ F1ǵF2ǵF3ǵϷ F4 ѤঁϩǶஒӚϩа HPSEC ϩǴམଛ ELISA assay
Չϩη่ᄬזೲᒣᆶϯᏢϩዴᇡǴ٬Ҕ LM2ǵLM5ǵLM6ǵLM7ǵLM10ǵ LM19ǵLM20 ᆶ JIM7 ՉխࣝᒃکϸᔈǶځύ LM2 Ϸ LM5 ᇡࣁёж߄ arabinogalactan type II (AGII) ᆶ arabinogalactan type I (AGI) ่ᄬǶF1 ᆶ F2 ӭᗐ
ϩܭᡶᐚࡋࣁ 0–0.1M ਔрǴಔԋࣁ arabinose ᆶ galactoseǴᆶ LM5ǵLM6 Ԗ ᒃکϸᔈǴ߄ҢڀԖ ß-(1→4)-galactan Ϸ linear arabinan ϩЍǶF3ǵF4 ӭᗐϩܭ ᡶᐚࡋࣁ 0.1–018M рǴڀԖለ܄ᑗ galacturonic acid ᆶ glucuronic acidǴԜΒ
ϩନΑჹܭ LM2ǵLM5 Ϸ LM6 ԖᒃکϸᔈѦǴаለ܄ᑗࣁЬाಔԋϐ F4 ჹܭ LM19 ڀԖ࣬ଯޑᒃک܄ǴᡉҢԜΒϩڀԖ partially methyl esterified HG аϷ RGI ่ᄬᆶ AGIǵAGII Ϸ linear arabinan ϩЍǴԜѦѤঁϩჹܭ LM10 ࣣคᒃ کϸᔈǴ٠όڀԖ xylogalacturonan ܈ xylan ่ᄬǶ
ᜢᗖӷǺଯਏૈϩηᑔቫݤǵሇનೱ่խࣝϩݤǵଯᏊໆ㸃ރਏᔈǵൂਲ਼ל ᡏǶ
Abstract
ġ ġ ġ This study used high performance size exclusion chromatography (HPSEC) and enzyme-linked immunosorbent assay (ELISA) to characterize the distribution of different epitopes within four fractions separated by DEAE chromatography of water soluble nondigestible polysaccharides. Water-soluble nondigestible polysaccharides were obtained from deproteinized crude polysaccharides subjected to starch hydrolyzing enzymes to remove the starch. DEAE chromatography can divide water-soluble nondigestible polysaccharides to four fractions (F1-F4) by different concentration of the eluent. Monoclonal antibodies have been widely used in studies of plant cell structures.
The mAbs LM2, LM5, LM6, LM7, LM10, LM19, LM20 and JIM7 were used in this research. The LM2 and LM5 resemble the AGII and AGI structures. F1 and F2 were observed when the eluent salt concentration was 0 to 0.1M. They are composed of arabinose and galactose, and the Mw are 71 and 116 kDa, respectively. Binding of F1 and F2 to LM5 and LM6 indicated the presence of RGI material with both arabinan and the AGI side chains. On the otherhand, F3 and F4 were observed when the eluent salt concentration was 0.1 to 0.18M. In addition to the arabinose and galactose, there are acidic polysaccharides such as galacturonic acid and glucuronic acid for F3 and F4.
Affinity to AGII (LM2), AGI (LM5), arabinan (LM6) and partially methyl esterified HG (LM19) were mainly observed in F3 and F4. It was also observed that F4 had a very high affinity to partially methyl esterified HG (LM19), indicating that it is mainly composed of an acid glycoprotein. Lastly, the four fractions had no observed immunoaffinity to LM10, indicating that there were no xylan or xylogalacturonan structures in the fractions.
Key word: high performance size excluion chromatography (HPSEC), enzyme-linked
immunosorbent assay (ELISA), the high dose hook effect, monoclonal antibody.Ҟ Ҟᒵ
ᖴᇞ ……….i
ᄔा ………...iii
Abstract ………...iv
Ҟᒵ ………I კҞᒵ ………...V ߄Ҟᒵ ………...VII ൘ǵق ... 1
ມǵЎӣ៝ ... 2
ಃകǵՋࢩୖ………2
ಃǵғނϩᜪ ... 2
ಃΒǵᄊቻ ... 2
ಃΟǵࢲ܄ԋϩ ... 2
3.1 ӭᗐᜪ ... 3
3.2 جҒᜪ ... 3
ಃѤǵғࢲ܄ ... 5
4.1 ڋ࡚܄ڥ֎ၰੰੱ ... 5
4.2 ڋဍዦғߏ ... 6
ಃΒകǵ݀ጤӭᗐ………7
ಃǵ่ᄬᆶϩᜪ ... 7
1.1 Homogalacturonan (HGA) ... 8
1.2 Xylogalacturonan (XGA) ... 9
1.3 Rhamnogalacturonan-I (RG-I)………10
1.3.1 Arabinan………..10
1.3.2 Arabinogalactan type I (AGI)………..10
1.3.3 Arabinogalactan type II (AGII)………...11
1.4 Rhamnogalacturonan II (RG-II)………..11
ಃΒǵ݀ጤӭᗐϐ่ᄬᆶғࢲ܄………...12
ಃΟകǵӭᗐޑϩᚆᆶપϯ………...15
ಃǵϩભ؈ᐘݤ………...15
ಃΒǵᡶݤ………...15
ಃΟǵߎឦᒱӝݤ………...15
ಃѤǵᆅࢊቫݤ………...16
4.1 ᚆηҬඤቫݤ……….16
4.1.1. ڰۓ࣬……….17
4.1.2. ࢬ࣬……….17
4.2 ϩηᑔᒧቫݤ……….17
4.2.1. ڰۓ࣬……….18
4.2.2. ౽࣬……….19
4.2.2.1.ׯᡂ pH ॶ………19
4.2.2.2.ׯᡂᡶᐚࡋ………...19
ಃѤകǵխࣝᔠෳБݤ………..……….20
ಃǵ୷ᘵϟಏ………...20
ಃΒǵלচᆶъלচᅿᜪ………...20
ಃΟǵלᡏᅿᜪ………...21
ಃѤǵሇનೱ่խࣝ֎ߕ၂ᡍ………...22
4.1 ڰۓ࣬……….22
4.2 ߔ༞……….22
4.3 ևՅᏊ……….22
4.4 ELISA БԄ……….23
ಃϖǵൂਲ਼לᡏ………...25
5.1 LM2 ൂਲ਼לᡏ………25
5.2 LM5 ൂਲ਼לᡏ………25
5.3 LM6 ൂਲ਼לᡏ………26
5.4 LM7 ൂਲ਼לᡏ………26
5.5 LM10 ൂਲ਼לᡏ………..26
5.6 LM19 ൂਲ਼לᡏ………..27
5.7 LM20 ൂਲ਼לᡏ………..27
5.8 JIM7 ൂਲ਼לᡏ………...27
5.9 ൂਲ਼לᡏᆶނಒझᏛӭᗐᒃکϸᔈϐᔈҔ ... 28
ୖǵ၂ᡍࢬำკ ... 32
စǵᆶБݤ ... 33
ಃകǵჴᡍ………..33
ಃǵՋࢩୖኬࠔ ... 33
1.1 ٰྍ ... 33
1.2 Нڗނϐᇙഢ ... 33
1.3 Нྋ܄ಉӭᗐϐᇙഢ ... 33
1.4 Нྋ܄ёϯӭᗐϷόёϯӭᗐϐᇙഢ ... 33
1.5 ᚆηҬඤᐋિቫϐНྋ܄όёϯӭᗐϩ ... 34
ಃΒǵჴᡍᛰࠔᆶ၂Ꮚ ... 35
2.1 ϯᏢᛰࠔᆶ၂Ꮚ ... 35
2.2 ྗࠔ ... 36
2.3 לᡏ ... 36
2.4 ሇન ... 36
2.5.1.ᕗለፂనଛᇙ ... 36
2.5.2.όӕ pH ॶϐᕗለፂనଛᇙ ... 36
2.5.3.όӕ NaCl ᐚࡋϐᕗለፂనଛᇙ... 37
ಃΟǵሺᏔഢ ... 37
ಃѤǵϯᏢϩБݤ ... 38
4.1 ᕴᗐ֖ໆෳۓ ... 38
4.2 α-D-glucose ֖ໆෳۓ ... 38
4.3 ⾺ᑗለ֖ໆෳۓ ... 38
4.4 ೈқ፦֖ໆෳۓ ... 39
4.5 KDO ֖ໆෳۓ ... 39
4.6 ሇનೱ่խࣝ֎ߕݤ ... 39
4.7 ൂᗐಔԋϩ ... 40
4.7.1. ࡑෳኬࠔೀ………40
4.7.2. ΟࢧᎉለНှ………..………..40
4.7.3. Ҙ✊ϯϸᔈ………41
4.7.4. ϩس………41
4.8 ϩηໆෳۓ ... 42
4.8.1. ࡑෳኬࠔೀ………42
4.8.2. ྗࠔ………42
4.8.3. ϩس………42
4.9 HPSEC Սᖄ ELISA assay ... 43
ಃϖǵीϩ ... 43
Ҵǵ่݀ᆶፕ ... 44
ಃകǵНྋ܄όёϯӭᗐ………..44
ಃǵНྋ܄όёϯӭᗐϩϐಔԋϩ ... 44
ಃΒǵНྋ܄όёϯӭᗐύӚӭᗐϩϐϩηໆ ... 46
ಃΒകǵሇનೱ่խࣝ֎ߕϩݤനϯచҹϩ………..50
ಃǵCoating buffer ϐ pH ॶᆶᚆηமࡋჹלচ֎ߕϸᔈϐቹៜ .. 50
ಃΒǵଯᏊໆ㸃ރਏᔈ ... 54
ಃΟകǵНྋ܄όёϯӭᗐύӚӭᗐϩϐൂਲ਼לᡏᒃکΚ่݀……..61
ഌǵ่ፕ ... 69
ࢠǵୖԵЎ ... 71
ǵߕᒵ ... 87
კ
კҞᒵ
კǵՋࢩୖύجҒޑϯᏢ่ᄬǶ ... 5
კΒǵ݀ጤӭᗐ่ᄬǴЬाёϩࣁ Homogalacturonan (HGA)ǵ Rhamnogalacturonan-I (RG-I) Ϸ Rhamnogalacturonan-II (RG-II)Ƕ ... 8
კΟǵHomogalacturonan ่ᄬკǶ... 9
კѤǵXylogalacturonan ่ᄬკǶ... 9
კϖǵRhamnogalacturonan-I ่ᄬკǶ ... 10
კϤǵArabinan ่ᄬკǶ ... 10
კΎǵArabinogalactan type I ่ᄬკǶ ...11
კΖǵArabinogalactan type II ่ᄬკǶ ...11
კΐǵRhamnogalacturonan II ่ᄬკǶ ... 12
კΜǵ܌Ԗᡏᑈ (Vt)ǵᆅࢊᗭಈѦޑᡏᑈ (Vo)ǵᆅࢊᗭಈϣޑᡏᑈ (Vi) ᆶᅉ੮ ᡏᑈ(Ve)ϐᜢ߯ҢཀკǶ ... 18
კΜǵޔௗϷ໔ௗխࣝ֎ߕ၂ᡍǶ ... 23
კΜΒǵਂਆϷᝡݾխࣝ֎ߕ၂ᡍǶ ... 24
კΜΟǵൂਲ਼לᡏᒣᇡלচ،ۓՏ (epitope) ෳӭᗐ่ᄬǶ... 29
კΜѤǵՋࢩୖНྋ܄όёϯӭᗐа DEAE ቫϩკǶ ... 46
კΜϖǵՋࢩୖНྋ܄όёϯӭᗐа DEAE ቫϩᚆϐ F1 ϩηໆკǶ ... 47
კΜϤǵՋࢩୖНྋ܄όёϯӭᗐа DEAE ቫϩᚆϐ F2 ϩηໆკǶ ... 48
კΜΎǵՋࢩୖНྋ܄όёϯӭᗐа DEAE ቫϩᚆϐ F3 ϩηໆკǶ ... 48
კΜΖǵՋࢩୖНྋ܄όёϯӭᗐа DEAE ቫϩᚆϐ F4 ϩηໆკǶ ... 49
კΜΐǵόӕᐚࡋ gum arabic ྋܭΒԛᇃᚖНᆶൂਲ਼לᡏ LM2 ϐᒃکΚϩǶ ... 52
კΒΜǵόӕᐚࡋ gum arabic ྋܭᕗለፂనᆶൂਲ਼לᡏ LM2 ϐᒃکΚϩǶ ... 52
კΒΜǵόӕᐚࡋ gum arabic ྋܭ HPSEC ࢬࢱనᆶൂਲ਼לᡏ LM2 ϐᒃکΚϩ Ƕ ... 53
კΒΜΒǵόӕ pH ॶϐᕗለፂనჹܭ gum arabicǵcitrus pecitnǵ(1→5)-α-L- arabinan ᆶ 4-O-methyl-glucuronoxylan Ϸൂਲ਼לᡏ LM2ǵLM5ǵLM6 ᆶ LM10 ϐ֎ӀॶቹៜǶ ... 53
კΒΜΟǵόӕෛϯ໊ᐚࡋϐᕗለፂనჹܭ gum arabicǵcitrus pecitnǵ(1→5)- α-L-arabinan ᆶ 4-O-methyl-glucuronoxylan Ϸჹᔈϐൂਲ਼לᡏ LM2ǵLM5ǵ LM6 ᆶ LM10 ϐ֎ӀॶቹៜǶ ... 54
კΒΜѤǵόӕᐚࡋྗࠔྋܭᕗለፂనᆶൂਲ਼לᡏᒃکΚ่݀Ƕ ... 55
კΒΜϖǵόӕᐚࡋྗࠔྋܭ HPSEC ࢬࢱనᆶൂਲ਼לᡏᒃکΚ่݀Ƕ... 56 კΒΜϤǵόӕᐚࡋ gum arabic ྋܭᕗለፂనᆶൂਲ਼לᡏ LM2 ϐᒃکΚϩ
კΒΜΎǵόӕᐚࡋ gum arabic ྋܭ HPSEC ࢬࢱనᆶൂਲ਼לᡏ LM2 ϐᒃکΚ ϩǶ ... 57 კΒΜΖǵόӕᐚࡋ citrus pectin ྋܭᕗለፂనᆶൂਲ਼לᡏ LM5 ϐᒃکΚϩ
Ƕ ... 57 კΒΜΐǵόӕᐚࡋ citrus pectin ྋܭ HPSEC ࢬࢱనᆶൂਲ਼לᡏ LM5 ϐᒃکΚ
ϩǶ ... 58 კΟΜǵόӕᐚࡋ(1→5)-α-L-arabinan ྋܭᕗለፂనᆶൂਲ਼לᡏ LM6 ϐᒃکΚ
ϩǶ ... 58 კΟΜǵόӕᐚࡋ(1→5)-α-L-arabinan ྋܭ HPSEC ࢬࢱనᆶൂਲ਼לᡏ LM6 ϐ
ᒃکΚϩǶ ... 59 კΟΜΒǵόӕᐚࡋ 4-O-methyl-glucuronoxylan ྋܭᕗለፂనᆶൂਲ਼לᡏ
LM10 ϐᒃکΚϩǶ ... 59 კΟΜΟǵόӕᐚࡋ 4-O-methyl-glucuronoxylan ྋܭ HPSEC ࢬࢱనᆶൂਲ਼לᡏ
LM10 ϐᒃکΚϩǶ ... 60 კΟΜѤǵόӕᐚࡋ citrus pectin ྋܭᕗለፂనᆶൂਲ਼לᡏ LM20 ϐᒃکΚϩ
Ƕ ... 60 კΟΜϖǵόӕᐚࡋ citrus pectin ྋܭ HPSEC ࢬࢱనᆶൂਲ਼לᡏ LM20 ϐᒃکΚ
ϩǶ ... 61 კΟΜϤǵՋࢩୖНྋ܄όёϯӭᗐа DEAE ቫϩᚆϐ F1 ᆶൂਲ਼לᡏ
LM2ǵLM5ǵLM6ǵLM7ǵLM10ǵLM19ǵLM20 ᆶ JIM7 ϐᒃکΚϩǶ ... 64 კΟΜΎǵՋࢩୖНྋ܄όёϯӭᗐа DEAE ቫϩᚆϐ F2 ᆶൂਲ਼לᡏ
LM2ǵLM5ǵLM6ǵLM7ǵLM10ǵLM19ǵLM20 ᆶ JIM7 ϐᒃکΚϩǶ ... 65 კΟΜΖǵՋࢩୖНྋ܄όёϯӭᗐа DEAE ቫϩᚆϐ F3 ᆶൂਲ਼לᡏ
LM2ǵLM5ǵLM6ǵLM7ǵLM10ǵLM19ǵLM20 ᆶ JIM7 ϐᒃکΚϩǶ ... 66 კΟΜΐǵՋࢩୖНྋ܄όёϯӭᗐа DEAE ቫϩᚆϐ F4 ᆶൂਲ਼לᡏ
LM2ǵLM5ǵLM6ǵǵLM7ǵLM10ǵLM19ǵLM20 ᆶ JIM7 ϐᒃکΚϩǶ ... 67
߄
߄Ҟᒵ
߄ǵНྋ܄όёϯӭᗐҗ DEAE ቫ܌ϩᚆޑѤᅿϩቫӭᗐϐ୷ҁಔԋǶ ... 45 ߄ΒǵНྋ܄όёϯӭᗐҗ DEAE ቫ܌ϩᚆϐѤঁϩӭᗐځӚձൂᗐಔ
ԋǶ ... 45 ߄ΟǵНྋ܄όёϯӭᗐҗ DEAE ቫ܌ϩᚆϐѤᅿϩӭᗐځӚձϩη
ໆǶ ... 49 ߄ѤǵНྋ܄όёϯӭᗐа DEAE ቫϩᚆϐѤঁϩڀԖϐ݀ጤ่ᄬំ
߄Ƕ ... 68
൘
൘ǵġق
ġ ġ Ջࢩୖӭᗐឦܭ݀ጤӭᗐǴᇡࣁЬाගٮխࣝፓࢲ܄Ǵӵڈᐟ TNF-αǵ IFN-γ Ϸ IL-2 ញܫǴёफ़եࢬՉ܄གߵᐒၲ 89%ǴҞςԖᛰࠔѱǴԶ݀ጤӭ ᗐځ่ᄬፄᚇǴа۳ࣁှࢲ܄ӭᗐϐֹ่ᄬǴӭՉ़ғϯǴ٬Ҕ GC-MS Ϸ NMR ሺᏔמೌǴલᗺࣁሡाપࡋଯޑኬࠔϷεໆޑਔ໔Ƕ
ġ ġ ൂਲ਼לᡏҞςදၹ٬Ҕܭࣴزނಒझ่ᄬǴᒣձނಒझวၸำύǴځ ӭᗐޑׯᡂǶ
ġ ġ ҁ ፕ Ў ٬ Ҕ ଯ ਏ ૈ ϩ η ᑔ ቫ ݤ (high performance size excluion chromatography, HPSEC) མଛሇનೱ่խࣝϩݤ (enzyme-linked immunosorbent assay, ELISA),Ǵ٬Ҕൂਲ਼לᡏ LM2ǵLM5ǵLM6ǵLM7ǵLM10ǵLM19ǵLM20 ᆶ JIM7Ǵځלচ،ۓՏϩձࣁ ß-linked glucuronic acidǵß-(1→4)-galactanǵα-(1→5)- L-arabinanǵß-(1→4)-xylan Ϸ partially methyl α-(1→4)-GalAǴᙖҗלᡏᆶלচ،ۓ Տϐᒃک܄ǴࡌҥᔠෳѳѠǴଞჹՋࢩୖНёྋ܄Ӛᅿӭᗐϐϩη่ᄬቻ
ՉϩǶ
ມ
ມǵġЎӣ៝
ಃകǵġՋࢩୖ(Panax quinquefolius Linn)
ՋࢩୖǴΞӜᄡୖǵણӀୖǵՋࢩΓୖǵቶܿΓୖǵࢩୖǴচౢԾऍ ୯чډу৾εࠄǴܭ࠶ථநٌԀౢໆࣁനεے(Wang and Yuan, 2008)ǶȨҁӆ
ཥȩᇡࣁՋࢩୖԖڰᆒӼઓϐਏǴȨᙴᏢ૱ύୖՋᒵȩ߾ᇡࣁځૈံշϩǴঋૈ
ံՈϩǴࣁځ܄థԶံǴΥటҔΓୖԶόڙΓୖϐྕံޣࣣёаԜжϐǶᛰ܄ࣁ ښҒǵधǵ܄థǶΕЈǵޤǵΟǴڀԖޤǵమОǵᎦगғࢭϐਏǴҔܭ ޤΦࠏǵྠ॰ੱ(,2003)Ƕ
ಃġǵғނϩᜪ
! ! Ջࢩୖࣁϖуࣽ (Araliaceae)ǵΓୖឦ (Panax)ǴӭԃғҁނǶӕឦނԖ
Panax ginseng C. A. Meyer (٥ࢪΓୖ)ǵ Panax notoginseng (Burk.) F. H. Chen
(Ο Ύ)Ǵࣣࣁᛰ٬Ҕ(Chen et al., 2001; Wang et al., 2007 ) ǶಃΒġǵᄊቻ
! ! ਲ਼ӄᡏคЛǴਥϩࣁЬਥǵ݄ਥکᠣਥǴԺ፦Ǵ߄य़ԖుభಉಒόޑᐉદǶ όӕԃសՋࢩୖЬਥᒿ⭂សቚуǴڬҜǵԛғҜکЕ፦य़ᑈǴ֡ևቚуᖿ༈Ƕ ਥޑᖓᏛಔᙃಒझϣᓯᙒᙦޑᐘણಈǴӧวػғߏύǴևۓೕࡓ܄ޑᡂϯǶ ਥکӦಳҬೀԖӦΠಳǴᆀࣁਥಳǴዬރǴಳࣁ༝ࢊǶඓރϖрፄယǴယ ևॹռ܈ߏᐍ༝ǴӃᆄँӾǴᜐጔڀԖόೕ߾ಉᒯᏁǴ୷ևུǶദׇࠠǴ ዀ݀ࡧ༝Ǵԋዕࣁుआ(,1990)Ƕ
ಃΟġǵࢲ܄ԋϩ
! ! ΓୖਥࣁᛰςຬၸٿίᎩԃǴߏΦаٰຎࣁᡫϏ֮ᛰ (panacea)Ǵ
ڀԖۯԃტϐфਏǴࢲ܄ނ፦ЬाࣁӭᗐᜪǵجҒᜪǵᴏ两ᜪǵᆫΌᬨᎇ (polyacetylenic alcohol) Ϸિެለ(Lee, 1992; Attele et al., 1999) Ƕ
3.1
ӭӭᗐᜪ! ! ՋࢩୖӭᗐڀԖቚխࣝϸᔈޑૈΚǴڈᐟరЃಒझ (lymphocyte) ǵϟ қ፦ (interleukin) ǵဍዦᚯԝӢη (tumor necrosis factor) ࢲ܄(Ma et al., 1998;
Assinewe et al., 2002) Ƕ а Ջ ࢩ ୖ ӭ ᗐ ೀ λ Ⴕ ࡕ ག ࢉ қ Յ ۺ ੧ (Candida
albicans)Ǵೀಔ࣬ၨܭჹྣಔܴᡉफ़եқՅۺ੧ܭ᠌ޑਏሽ (titer)ǵ෧Ͽ
᠌ ᆶՈమ ύ วݹಒ झ Ӣη (inflammatory cytokine) MCP-1 ᆶ MIP-2 ޑ ౢғ (Trammell et al., 2012)Ǵ٠Ъӧᡏϣ (in vivo) ჴᡍύวǴՋࢩୖӭᗐቚуߎՅ ဟౚ (Staphylococcus aureus) གࢉλႵϐӸࢲǵ෧ϿࢲϯѮᏘಒझϷՈనύ
༾ғނ֖ໆ(Lim et al., 2002; Ahn et al., 2006)ǶჹܭޤဍዦλႵ (Lewis tumor-bearing C57BL/6 mice)ǴՋࢩୖӭᗐᡉڋဍዦғߏǵቚуխࣝᏔ۔ϐૅဏϷ᠌ख़ໆǴ ڈᐟ IL-2 Ϸ IFN-γ ߄ǴҗԜёޕǴՋࢩୖӭᗐаࢲϯ Th-1 ಒझࣁЬ(Zhu et al., 2012)Ƕ
3.2
جҒᜪ! ! جҒࣁՋࢩୖޑЬाࢲ܄ԋϩǴҞςԖӭᅿجҒᜪϩᚆǴϯᏢ่ᄬ
ᆶᎇᜪᗖ่ޑᑗᜪࣁဟᑗǵഝᑗǵ݀ᑗϷጧᑗ(Gillis, 1997; Yoshikawa et al., 1998)Ǵܭ C-3ǵC-6 ܈ C-20 ՏǴӢᑗಔԋϷᗖ่Տৡ౦Ꮴठόӕޑғࢲ܄
(Attele et al., 1999)ǶRh1 ᆶ Rh2 ่ᄬ࣬՟Ǵόӕᗺࣁ ß-D-glucopyranosyl group ᗖ
่ܭ Rh1 ޑ C-6 ᆶ Rh2 ޑ C-3 ՏǴRh2 ёаڋ B16-BL6 Յનዦಒझғߏǵ ڈᐟՅનғӝԋϷಒझ໔ᗹߕ܄ǴԶ Rh1 ჹܭಒझࠅคԜբҔ(Odashima et al., 1985)ǶՋࢩୖجҒᜪύǴRb1 Ϸ Rg1 ڀԖڈᐟǵڋύኰઓسϷፓઓ
ᏤϐբҔǶύኰᖌᡵૈس (Central cholinergic systems) ॄೢᏢಞϷᏫၸำ (Perry, 1986)ǴRb1 ቚуسύᖌᡵޑឪڗໆ(Benishin, 1992)Ǵ٬Όㄽᖌᡵҗੇଭ
ύញܫ(Benishin et al., 1991)ǴԶளޕՋࢩୖجҒڀԖߦᏢಞǵᏫၸำϷઓ
ғߏૈΚ(Takemoto et al., 1984; Salim et al., 1997)ǶTsang ΓࡰрǴՋࢩୖڗނ
ڋ GABA ǵكለ (glutamate)ǵӭЃữ (dopamine) ǵ҅ဏન (noradrealin) Ϸ Ո మ ન (serotonin) ܭεႵတ ँ λᡏޑ ֎ԏڀԖ ᐚࡋ ਏᔈ (concentration- dependent) (Tsang et al., 1985a)ǶՋࢩୖڗނᆶ GABAAڙᡏ่ӝϐଛᡏ (ligand) ໔ޑբҔǴቹៜ GABAergic ઓᏤǴࣁՋࢩୖϐख़ाࢲ܄ԋϩ(Yuan et al., 1998)Ƕ ନԜϐѦǴKenarova วǴRg1 ᙖҗߦᇶշࠠ T ಒझ (T helper cell)ǵT రЃಒ झ (T lymphocyte) ᆶԾฅఠЋಒझ (NK cell) ғԋǴගϲխࣝϸᔈ(Kenarova et al., 1990)Ƕ
კǵՋࢩୖύجҒޑϯᏢ่ᄬǶ
Figure 1. Structures of ginsenosides discussed in the text. Based on chemical structure, there are two major groups: panaxadiols (A) and panaxatriols (B). Rh3, as shown in the lower part of (A), differs from other panaxadiols at the side chain. Ginsenoside Ro, a nonsteroidal saponin, is shown in (C).(Attele et al., 1999)
ಃ
ಃѤġǵғࢲ܄
4.1
ڋ࡚܄ڥ֎ၰੰੱ! ! Cytotoxic T lymphocytes or CTLs ࢂҗ Tc (T cytotoxic) ಒझౢғǴڀԖᒣᇡǵ
ྐᎁڙׯᡂޑԾᡏಒझ (altered self cell)ǴӵੰࢥགࢉಒझǵဍዦಒझǶԶ قǴCTLs ࣁ CD8+Ǵឦܭ class I MHCǶCTL ୖᆶޑխࣝϸᔈёϩࣁٿঁ໘ࢤǴ२ Ӄ native Tc ಒझୖᆶࢲϯϷϩϯࣁ functional effector CTLs ǹӆޣǴeffector CTLs ᒣᇡלচǴ٬ϐᚯǶNative Tc ಒझคݤྐלচǴຎࣁ CTL precursor (CTL-
P)ǴԖ CTL-P ࢲϯࡕωڀഢྐѦٰಒझૈΚǶӭኧಒझߞ৲ஒ CTL-P ࢲ ϯϷቚǴځࣁ IL-2 (interleukin-2)ǶIL-2 ࣁख़ा T ಒझԋߏӢηǴቚуխࣝౚ
ೈқӝԋǵԾฅఠЋಒझޑಒझྋှૈΚ (cytolytic activity) (Leonard, 1999)Ƕӧ IL- 2 knock out λႵύวǴલϿ IL-2 ߾ቲЗ CTL фૈǴלচమନϐࡕǴIL-2 ֖ ໆ෧ϿǴёᇨᏤ CTL ಒझΫวғǴ่״խࣝϸᔈ(Thomas et al., 2007)ǶCOLD- fX (CVT-E002) ࢂҗՋࢩୖਥڗϐံкࠔǴ֖ poly-furanosyl-pyranosyl- saccharidesǴӵႵᑗǵဟᑗǵъ٢ᑗǵߓդᑗϷъ٢ᑗ⾺ለǶа COLD-fX ೀ
ڙ Con-A ᇨᏤλႵ᠌ಒझϷڙࢬՉ܄གߵੰࢥགࢉϐΓᜪڬᜐՈనൂਡౚಒ झ (peripheral blood mononuclear cell) Ǵࣣܴᡉቚу IL-2 Ϸ IFN-γ ౢғ(Wang et al., 2004; McElhaney et al., 2006)ǶMcElhaney Γஒ COLD-fX ܭࢬՉ܄གߵӳวۑ
๏ϒ 198 ՏԋΓܺҔၲ 4 ঁДǴफ़եӢࣁࢬགੰࢥ (influenza) ܈ڥ֎ၰᑼӝੰࢥ (respiratory syncytial virus) ܌Їวϐ࡚܄ڥ֎ၰੰੱ (acute respiratory illness, ARI)
ၲ 89%ǴԶࡕܕ 43 ՏǴ65 ྃаޑ଼நԋԃΓǴ22 Տ๏ϒ COLD-fXǴځᎩ 21 Տ๏ϒӼኃᏊǴ4 ຼࡕݙࢬՉ܄གߵࣝभǴ่݀ᡉҢǴܺҔ COLD-fX ಔձၨჹ
ྣಔ෧Ͽ 48% ᐒᑡڥ֎ၰགࢉ੯ੰ(McElhaney et al., 2004; McElhaney et al., 2006)Ƕ
4.2
ڋဍዦғߏ! ! p21 (ಒझຼයڋೈқ,cyclin inhibitor protein) ࣁלဍዦࢲ܄ϐख़ाᜢᗖ Ǵᗖ่ܭಒझຼය٩ᒘᐟ䁙 (cyclin-dependent kinase, CDK)Ǵڋሇનࢲ܄ǵߔЗ DNA ӝԋϷߔᘐಒझຼයǴ٠ԖࣴزᡉҢǴՋࢩୖڗނᙖҗϣӧΫ৩Ǵׯ ᡂ BaxǵBidǵcaspase-3 ᆶ PARP ೈқ፦߄ǴаϷಈጕᡏጢႝՏᆶ cytochrome c ញܫǴߦဍዦಒझԝΫ(Oh and Lee, 2004; Oh et al., 2005; Yang et al., 2006; Koo
et al., 2007)ǶаՋࢩୖڗނೀ HCT116 Γᜪ่ဉᕎಒझ 48 λਔǴՋࢩୖڗ
ނԖշܭ෧ϿಒझኧҞǵ٬ಒझଶᅉܭ G0/G1 යǴڋ HCT116 ಒझቚǴ٠วೀࡕಒझϐ p53ǵp21 ϷߦಒझΫೈқ Bax ֖ໆࣣቚуǴphospho-MEK ߾෧ ϿǴԖշܭߔᘐಒझຼයǵ෧Ͽಒझߞ৲(King and Murphy, 2010)Ƕ
ಃ
ಃΒകǵġ݀ጤӭᗐ
! ! ݀ጤࣁԾฅࣚύፄᚇޑӭᗐ่ᄬǴ35%ՏܭᚈηယނϷߚңҁࣽൂηယ
ނϐ߃ભಒझᏛǴ2-10%ܭҁނǵ5%ܭЕҁނಔᙃ(O'Neill et al., 1990; Ridley
et al., 2001)ǴЬाӸӧՉғߏϩϐಒझᏛϷύጤቫǶ݀ጤᔅշނғߏǵว
ػǵᄊғԋǵٛᑇǵಒझᗹǵЍಒझᏛϷߞ৲Ꮴ(Ridley et al., 2001; Willatset al., 2001)ǶᔈҔܭ१ࠔБय़ǴࣁԋጤᏊϷᛙۓᏊǴςԖࣴزࡰрǴ݀ጤёफ़ե
ᖌڰᎇϷՈనύဟᑗᐚࡋǵڋᕎੱǵڈᐟխࣝϸᔈ(Inngjerdingen et al., 2007;Jackson et al., 2007)Ƕ
ಃġǵ่ᄬᆶϩᜪ
! ! ݀ጤӭᗐҔа߄Ң֖ъ٢ᑗ⾺ለޑӭᗐǴԿϿ 10 ঁൂᡏ܌ಔԋϐߏъ٢ ᗐ⾺ለ (homogalacturonan)(Nothnagel et al., 1983; Samuelsen et al., 1996a)ǴΨத ـߓդᑗǵъ٢ᑗǵႵᑗύ܄ᑗǶለ܄౦፦ӭᗐǴڀӭϩη܄ (polymolecular) Ϸӭϩණ܄ (polydisperse)ǴϩηໆϩѲጄൎଯၲ 100 kDaǴځಔԋӢࣁނٰྍǵ
ڗБԄԶ౦Ƕ݀ጤӭᗐёᘜયрڂ่ࠠᄬǴମࢎࣁ 1ʈ4 ᗖ่ޑъ٢ᑗ⾺ለǴ Ь ा ϩ ࣁ Homogalacturonan (HGA) ǵ Rhamnogalacturonan-I (RG-I) Ϸ Rhamnogalacturonan-II (RG-II) (Pérez S et al., 2003)Ƕ
კΒǵ݀ጤӭᗐ่ᄬǴЬाёϩࣁ Homogalacturonan (HGA)ǵ Rhamnogalacturonan-I (RG-I) Ϸ Rhamnogalacturonan-II (RG-II)Ƕ
Figure 2. Schematic representation of the “canonical” primary structure of pectins. For the sake of simplicity, the schematic representation of HGA, RG-I, and RG-II is given assuming that these three domains are covalently linked, although this points is not firmly established(Pérez S et al., 2003).
1.1 Homogalacturonan (HGA)
! ! ̄omogalacturonan ࣁ 1,4 ᗖ่ޑޔъ٢ᑗ⾺ለ (GalpA) ่ᄬǴ՞݀ጤ 65%Ǵ
ϩ♐୷ԖҘ୷অႬǴܭ C-3 ܈ C-2 ՏڀΌㄽ୷(Ishii, 1995; 1997)ǴЍၨϿǴ Ξᆀࣁѳྖ (smooth region)Ƕ҂Ҙ୷ϯޑ HGA ॄႝǴᆶ Ca2+բҔԋᛙۓጤ ᡏǴࢂ݀ጤϐЬाᏉጤᐒڋ(Liners et al., 1989; Jarvis and Apperley, 1995)Ƕ
კΟǵHomogalacturonan ่ᄬკǶ
Figure 3. The primary structure of homogalacturonan(Ridley et al., 2001)
1.2 Xylogalacturonan (XGA)
! ! Xylogalacturonan ࣁ homogalacturonan ځ C-3 Տа ß-D-xylose ڗж(Aspinall, 1980; O'Neill et al., 1990; Schols et al., 1995; Kikuchi et al., 1996; Yu and Mort, 1996)Ǵ
ӸܭғಔᙃǴӵلᜪᅿηǵ݀ჴϷણǶࣴزวǴӝԋ xylogalacturonan ࢂ ҔаჹלੰচװᔐǴ٬ homogalacturonan ၨૈܢלੰচౢғϐϣᆫъ٢ᑗ䁙 (endopolygalacturonase) (Jensen et al., 2008)Ƕ
კѤǵXylogalacturonan ่ᄬკǶ
Figure 4. Structure of a part of xylogalacturonan(O'Neill et al., 1990)
1.3 Rhamnogalacturonan-I (RG-I)
! ! Rhamnogalacturonan ޑ่ᄬЬाࣁ→4)-α-D-GalpA-(1→2)-α-L-Rhap-(1→Ǵ՞݀
ጤ 20-35%ǴGalpA ޑ C-3 ܈ C-2 ՏΌㄽϯ(Komalavilas and Mort, 1989)ǴRhap ޑ C-4 Տ߾ύ܄Ϸለ܄ᑗڗжǴ܈ೱௗ α-1,5 ᗖ่ޑߓդᑗ (α-1,5-linked-L-Araf) Ϸ ß-1,4 ᗖ่ޑъ٢ᑗ (ß-1,4-linked-D-Galp) ԋୁЍ(O'Neill et al., 1990; Carpita and Gibeaut, 1993)Ǵёϩࣁ ArabinanǵArabinogalactan type I Ϸ Arabinogalactan type IIǶԜၨӭϩЍǴΞᆀࣁӭЛ (hairy region, or ramified region) (Nakamura et al., 2002; Paulsen and Barsett, 2005)Ƕ
კϖǵRhamnogalacturonan-I ่ᄬკǶ
Figure 5. Structure of a part of rhamnogalacturonan-I(Komalavilas and Mort, 1989)
1.3.1 Arabinan
! ! Arabinan җ L-arabinose ܌ಔԋǴதௗܭ݀ጤ galactan ǴЬाࣁ 3,5 ᗖ่ǴӢ
ٰྍόӕԶԖޔ܈ୁЍ่ᄬǶԶقǴମ༸а 1ʈ5 linking ࣁЬǴϩЍЬाӧ C-3 ՏǴC-2 ࣁୋǶڗၸำ٬Ҕሇન܈ለНှёஒځញܫрٰ(Paulsen and Barsett, 2005)Ƕ
კϤǵArabinan ่ᄬკǶ
Figure 6. Structure of a part of an arabinan(Paulsen and Barsett, 2005).
1.3.2Arabinogalactan type I (AGI)
! ! Arabinogalactan type I ࣁ ß-1,4-linked-D-galactanǴӧ C-3 Տௗа arabinan ᄬ
ԋϩЍ(Jermyn and Yeow, 1975; Van Holst and Clarke, 1986; Huisman et al., 2001)Ƕ
კΎǵArabinogalactan type I ่ᄬკǶ
Figure 7. Structure of Arabinogalactan type I (Clarke et al., 1979)
1.3.3 Arabinogalactan type II (AGII)
! ! Arabinogalactan type II ࣁ ß-(1ʈ3)-D-galactanǴЍ ß (1ʈ6)-D-galactan ߾த
Araf ܈ ArapǵRhamǵXylǵGlcA ܌ڗжǴϩЍᗺӧ 1,3,6-linking GalǴڀԖଯࡋϩ ЍǶAGII ᆶ Yariv reagent ౢғआՅ؈ᐘ(Jermyn and Yeow, 1975; Van Holst and Clarke, 1986)ǶAGII தᆶೈқ፦่ӝᄬԋ Arabinogalactan protein (AGP)ǴAGII ܌՞Кٯε ܭ 90%Ǵೈқ፦՞ϿໆǶ(Pellerin et al., 1995; Luonteri et al., 2003)
კΖǵArabinogalactan type II ่ᄬკǶ
Figure 8. Structure of Arabinogalactan type II(Redgwell et al., 2002).
1.4 Rhamnogalacturonan II (RG-II)
! ! RG-II ࣁಔԋፄᚇޑӭᗐǴ՞݀ጤϐλϩǴऊ 10%(O'Neill et al., 2004)Ƕ
Ь༸җ 8 ঁаϐъ٢ᑗ⾺ለа α-1,4 ᗖ่܌ᄬԋǴܭ C-3 ܈ C-4 ՏೱௗԿϿ 12 ᅿᑗ୷Ǵԋ 20 ᅿаᗖ่Ǵཷౣёϩࣁϖᅿ (A~E)ǴၨڀՅޑࢂϩЍύр
شـޑൂᗐࣁ 2-O-methylfucoseǵ2-O-methylxyloseǵapioseǵaceric acidǵ2-keto-3- deoxy-D-manno-octulosonic acid (KDO) Ϸ 3-deoxy-D-lyxo-2-heptulosaric acid (DHA) (O'Neill et al., 1990; Doco et al., 1997; Pérez S et al., 2003; O'Neill et al., 2004)Ƕځύ KDO Ϸ DHA Ь ा Ӹ ӧ ܭ ើ М ܄ (gram-negative bacterial) ޑ િ ӭ ᗐ (lipopolysaccharides) ύǴԶ aceric acid ߾ѝวܭ RG-II ύǴӢԜ KDOǵDHA Ϸ aceric acid ёբ RG-II ϐቻ܄ൂᗐǴᙖа߃ղᘐ RG-II ϐӸӧ(York et
al., 1985)ǶಒझᏛऩ෧Ͽ RG-II ΒᆫᡏԋǴᄬԋᝄख़ޑғߏલഐǴӵٹᏂੱǴ
ࡺ RG-II ޑΒᆫϯჹܭނғߏวػཱུࣁख़ा(Mohnen, 2008)Ƕ
კΐǵRhamnogalacturonan II ่ᄬკǶ
Figure 9. Schematic representation of the primary structure of RG-II monomer(Pérez S
et al., 2003)
ಃ
ಃΒġǵ݀ጤӭᗐϐ่ᄬᆶғࢲ܄
! ! ύᛰނύޑ݀ጤӭኧڀԖלံᡏࢲ܄Ǵӵᘜ (Angelica
acutiloba)ǵਮच (Bupleurum falcatum) (Kiyohara et al., 1988; 1989a)ǵΓୖ (Panax ginseng) (Gao et al., 1988; Gao et al., 1990)ǵҒ (Glycyrrhiza uralensis) (Zhao et al.,
1991)Ϸً (Plantago major) (Samuelsen et al., 1996b)Ƕ݀ጤதـ่ᄬࣁ α- (1→4)-linked galacturonan Ǵ Ϸ rhamnogalacturonan ࣁ ମ ༸ Ǵ Ѝ ࣁ ύ ܄ ᑗ ӵ arabinogalactanǵarabinanǵgalacto-oligosaccharides ᄬԋޑӭЛ (ramified region) (Dey and Brinson, 1987)Ƕלံᡏࢲ܄ޑ݀ጤӭᗐǴڀԖ ß-3,6-galactan(Yamada et al., 1985b; Yamada et al., 1986; Samuelsen et al., 1996b)Ǵа α-L-arabinofuranosidase բҔ ࡕǴ٠όׯᡂ arabino-ß-3,6-galactan ޑࢲ܄Ǵᇥܴ (1→3,6)-ß-galactan ࣁלံᡏ ࢲ܄ϐख़ा่ᄬ(Yamada et al., 1987b; Kiyohara et al., 1988; 1989b; Yamada et al., 1989)Ƕ(1→3,6)-ß-galactan ёᆶ ß-glucosyl-Yariv antigen ᒱӝౢғआලՅ؈ᐘ(Clarkeet al., 1979)ǴҔܭᔠෳ (1→3,6)-ß-galactan ֖ໆ(Holst and Clarke, 1985; Kiyohara et al., 1989b; Gao et al., 1991)Ƕ
! ! ݀ጤޑለ܄ӭᗐϐύǴೱௗԿ rhamnogalacturonan ޑЍӵ arabinogalactan type I and II Ϸ 6-linked galacto-oligosaccharides ࢂࢲϯံᡏ alternative Ϸ classical ৩ޑЬा่ᄬǶGalacturonan ऩԖҘ୷✊ϯ (type I) ܈֖Ѝ (type II) ਔǴ߾
ڋ ramified region ޑғࢲ܄Ƕ
! ! Honda ΓࣴزวǴߏຬၸ 20 DP ޑӭᗐӵ ß-D-(1→3)-glucan ᆶ
alternative pathway ޑࢲ܄࣬ᜢǴԶҘ୷ (methyl group) ڋ ß-D-(1→3)-glucan ࢲ܄Ǵឍॊӭᗐޑҥᡏ่ᄬҭቹៜځ܄(Honda et al., 1986)Ƕ
! ! ΟᅿҗΓୖ (P. ginseng) ϩᚆрٰޑ݀ጤӭᗐ (GL-PIǵPIIǵPIV) ڀԖ לံᡏࢲ܄(Gao et al., 1988)ǴGL-PIII ߾คǴКၨӭᗐϐ໔ޑ่ᄬǴว GL-PIII ڀԖၨӭڀϩЍޑ galacturonanǴᇥܴ galacturonan ޑЍቹៜځࢲ܄(Gao et
al., 1990)Ƕ
! ! AGIIa ࢂҗᘜ (A. acutiloba) НڗనϩᚆԶளޑלံᡏӭᗐ (ځᎩϝԖ AGIIb-1 ǵ AR-2IIa ǵ AR-2IIb ǵ AR-2IIc Ϸ AR-2IId) Ǵ २ ԛ ว ύ ᛰ ύ ޑ
arabinogalactan ڀԖࢲϯံᡏфૈ(Yamada et al., 1985a)ǶAGIIa эᘜӭᗐλ
ϩǴࠅڀԖؼӳޑғࢲ܄ǶAGIIa ࣁ arabino ß-3,6-galactanǴڀԖ 5-linked α-L- arabinose Ϸ 3-linked ß-D-galactose ڗж୷Ǵҗ alternative ᆶ classical ৩ࢲϯ
ံᡏǶࣴزวǴӭኧڀԖࢲϯံᡏфૈޑ arabinogalactan ࣁ type IIǴՠࢂҗ larch wood ϩᚆрޑ type II arabinogalactan ߾όڀԖࢲϯံᡏϐфਏǶAR-2IIaǵ2IIbǵ 2IIc Ϸ 2IIdǴځ่ᄬࣁ 90%аޑ galacturonan Ϸ ramified region(Kiyohara et al., 1988) Ƕ Kiyohara Γ а endo-α-(1→4) polygalacturonase Ϸ ೀ ಥ ✊ ϯ (de- esterification) ݀ጤǴᇙഢ ramified region ኬࠔǴวԜၨচۈ݀ጤڀԖࢲϯံᡏ ࢲ܄ǴЪ AR-2IIa ޑ ramified region ڀԖεໆ(1→3,6)-ß-galacto-oligosaccharide chainsǴ ᡉҢ ramified region ࢂҗ ß-3,6-galactan ܌ᄬԋ٠ຎࣁࢲϯံᡏޑࢲ܄ୱ(Kiyohara
et al., 1988; 1989a)ǶAGIIb-1 ύלံᡏࢲ܄ޑᗐёᙖҗሇનϷϯᏢफ़ှ܌ளޕ
(Kiyohara et al., 1989c)Ǵ౽ନ AGIIb-1 ύ arabinan Ϸ arabinogalactan ޑ arabinose ϩ ЍǴёቚуࢲϯံᡏ alternative pathwayǴᡉҢ arabinose ϩЍڋ AGIIb-1 ࢲ܄(Yamada et al., 1987a; Zhang et al., 1996) Ƕ а arabinofuranosidase Ϸ exo-ß-D- (1→3)-galactanase ೀ AGIIb-1ǴНှ ß-(1→3)-galactan ମࢎ(Tsumuraya et al., 1990) Ϸ arabinogalactan side chainsǴౢғεໆޑ galactosyl oligosaccharide chainsǴՠࢂ
rhamnogalacturonan ϷځୁǴό galactanase НှǴϝ߄ᆶ AGIIb-1 ࣬ӕϐ
ံᡏࢲϯࢲ܄Ǵ߄Ң AGIIb-1 ޑࢲϯံᡏࢲ܄ЬाࣁᗐޑମࢎǴԶߚЍǶZhang
Γа Smith degradation Ϸ exo-ß-D-(1→3)-galactanaseǴࡰр AGIIb-1 ޑମࢎࣁᡉ
ࢲϯံᡏޑъ٢ჲᗐǴа 3- and 3,6-linked galactosyl residues ܌ಔԋǴҭ߄Ң ß-(1→3)-galactan ࣁ AGIIb-1 ޑЬा่ᄬ(Zhang et al., 1996)Ƕ
! ! ӭלံᡏ݀ጤӭᗐࣣ֖Ԗ arabino-3,6-galactan chainsǴᇥܴԜ่ᄬҭ
ࣁࢲ܄ӭᗐ(Yamada et al., 1985a; Yamada et al., 1986; Kiyohara et al., 1987; Yamada
et al., 1987a; Yamada et al., 1987c)ǶAGIIb-1 ለНှள arabino-3,6-galactan (N-
I)(Kiyohara et al., 1987)ǴӆҔ arabinofuranosidase Ϸ exo-ß-D-(1→3)-galactanase ೀ N-I ࡕϝڀԖלံᡏࢲ܄Ƕஒ N-I аጤᡏቫࡕளύϩηໆӭᗐǴࣁ GN-1A Ϸ GN-1BǴࣣڀԖံᡏࢲϯ܄ǴԜࢲ܄่ᄬࣁ 6-linked galactosyl residuesǴ߄Ң N- I ޑЍЬाҗ galactose ܌ᄬԋǴԶ 6-linked-ß-D-(1→3)-galactan ࣁࢲϯံᡏޑЬ
ाಔԋ(Kiyohara et al., 1997)Ƕ
! ! ࣁᕕှࢲ܄ӭᗐࢲϯံᡏᐒڋǴלᡏᆶࢲ܄ӭᗐޑᒃکϸᔈࣁؼӳ ᔠෳלচ،ۓՏ (epitope) ޑБݤǶҗਮचϩᚆளӭᗐ bupleuran 2IIb Ϸ 2IIcǴα
ܺᗯ१λႵǴ٬Ҕۓלᡏᔠෳלဍዦӭᗐ ramified region ϐϩѲ(Sakurai et
al., 1996)Ǵ่݀วӧط᠌ϷМඬ (Peyer's patches) ύǴԖۓϩηໆޑӭᗐᅉ
੮Ǵ߄Ңࢲ܄ӭᗐё֎ԏǵϯǴӧط᠌ՉжᖴǴԶځдӭᗐ߾ӧᆶڙᡏ่ӝ ࡕڈᐟӄي܈ဉၰޑխࣝಒझ(Czop et al., 1990)Ƕಃ
ಃΟകǵġӭᗐޑϩᚆᆶપϯ
ಃġǵϩભ؈ᐘݤ
! ! ϩભ؈ᐘݤࢂਥᏵόӕӭᗐӧόӕᐚࡋᎇǵ✉ύڀԖόӕྋှࡋޑ܄፦Ǵவλ ډεࡪКٯуΕҘᎇǵΌᎇ܈Ч✉Չϩભ؈ᐘ(ᇳ et al., 2007)Ƕ
ಃΒġǵᡶݤ
! ! ਥᏵόӕӭᗐӧόӕᡶᐚࡋύྋှࡋόӕԶஒځϩᚆޑᅿБݤǴதҔޑᡶ
ྋనԖෛϯ໊ǵෛϯႇϷ౷ለሓ(ᇳ et al., 2007)Ƕ
ಃΟġǵߎឦᒱӝݤ
! ! ճҔӭᗐૈᆶልǵ᎕ǵ້ϷႉᚆηԋᒱӝނԶ؈ᐘǴதҔᒱӝᏊԖත݅၂Ꮚǵ
ෛϯልǵణ਼ϯ᎕کᎉለႉ(ᇳ et al., 2007)Ƕ
ಃ
ಃѤġǵᆅࢊቫݤ
4.1 ᚆηҬඤቫݤ (ion exchange chromatography)
! ! ᚆηҬඤቫݤࣁதҔϩᚆБݤǴڗ،ܭௗӧೈқ፦ (܈ځдϩނ) ޑ҅
܈ॄႝ୷იǴڰۓܭڰۓ࣬Ǵӧ֎ߕၸำύǴ౽࣬ҬඤǶᚆηҬඤᐋિቫݤ ёϩࣁೱ่ (binding) کѐ֎ߕ (desorption) ϐၸำǴϩނೱ่ܭڰۓ࣬Ǵҗܭ ᡶᚆηᐚࡋ܈ pH ॶޑೱុ܈ఊࡋׯᡂǴ෧১ϩނᆶڰۓ࣬໔ޑҬϕբҔǴၲډ ϩᚆਏ݀ǶԶقǴ֎ߕکှନ֎ߕޑၸำࢂҗΟ࣬ϐ࣬ϕբҔ܌ౢғǴڰۓ࣬ǵ
౽࣬Ϸྋ፦ޑឦ܄ٰዴۓǶќБय़Ǵڰۓ࣬ᆶࢬ࣬ޑམଛࢂߚதӭϡޑǴԶ ЪϩނҁيӢࣁ pH ॶׯᡂځ߄य़܄ǴӵႝஏࡋϷႝ୷იޑ࣬ჹՏǶ ڰۓ࣬ޑวϩࣁҁيᚆηූ୷ޑஏࡋǵҥᡏۓӛϷ܄Ǵх֖ϯᏢ่ᄬǵᛙ ۓ܄ǵϾሜǵᗭಈЁκჹܭ่ӝΚڀԖᒧ܄ǴԶቹៜቫှࡋǶന߃Ҕа բࣁڰۓ࣬ޑࣁᠼᆢનǴೱௗΒΌ୷୷Ό✊ (diethylaminoethyl, DEAE) Ϸ♐Ҙ
୷ (carboxymethyl, CM)(Sober and Peterson, 1954; Sober et al., 1956)ǴϞаύ܄ᆫ ӝނӵጋᆒ (dextran)ǵᛏિ (agarose) Ϸӝԋᆫӝނӵᐋિ (resin) ࣁЬǶ
! ! ࣁၲډؼӳޑϩᚆϷගଯቫှࡋǴޑڰۓ࣬Ϸࢬ࣬ᒧߚதख़ाǴ ϩނ่ӝܭڰۓ࣬ޑமࡋёҗᚆηமࡋǵࢬ࣬ pH ॶǵᚆηҬඤޑႝமࡋϷ ϩނҁي܌ڋǶࢬ࣬ (܈ፂన) ޑᜪࠠǴх֖ణᚆηᐚࡋǴቹៜϩނ ޑࢲ܄Ϸྋှࡋ(Peterson and Torres, 1984; Cramer and Brooks, 1993)Ƕ
! ! ᚆηҬඤسёϩࣁᗖ่Ϸѐᗖ่ޑၸำǴϩނᗖ่Կڰۓ࣬Ǵᙖҗࢬ࣬
аೱុ܈ఊࡋޑ pH ॶ܈ᡶᐚࡋ٬ϩނᆶڰۓ࣬ޑҬϕբҔ෧১Ǵ܈ޣуΕᆶڰ ۓ࣬Ԗ ଯᒃ کΚ ޑϩ ηӵ carboxymethydextran ǵDEAE-dextran ǵdextransulfate (Cramer and Brooks, 1993)ǵampholyte(Leaback and Robinson, 1975) Ǵၲډؑගϩᚆ ϐਏ݀Ƕ
4.1.1.ڰ
ڰۓ࣬! ! ᚆηҬඤϐڰۓ࣬ڀԖٿঁ่ᄬǴႝ୷იୖᆶҬඤၸำǴаϷஒϐڰۓޑ୷
፦Ǵࣣቹៜቫ่݀Ƕႝ୷იޑႝϷமࡋ،ۓϩނᗖ่ޑ౦܄ϷமࡋǴ Զ୷፦߾ቹៜނϯӼۓ܄ǵڰۓ࣬ޑࢬ܄Ϸߚ܄ᗖ่Ƕёၲډޑႝமࡋ ϷᚆηҬඤޑ่ӝՏᗺڗ،ܭ୷፦ޑϯᏢ܄፦ᆶΟᆢ่ᄬǴԶᗭಈޑЁκελǵޔ ৩ϩѲϷϾሜࡋࣁ،ۓቫှࡋϐख़ाୖኧǶڰۓ࣬ёಉϩࣁѤᜪǴ১ᚆηǵ மᚆηǵ১ᚆηϷமᚆηǶᚆηޑம১ᆶϩނᗖ่ޑமࡋคᜢǴ߄Ңځှ
ᚆำࡋǴமᚆηၨ১ᚆηૈӧၨቨޑ pH ॶጄൎύှᚆǴٰᇥǴ১ᚆη
ӝϐ pH ॶࣁ 5.5-9.5ǴԶமᚆη߾ёᔈ pH ॶ 2-12Ƕ
4.1.2.ࢬ࣬
! ! ᚆηҬඤسϐख़ाୖኧࣁࢬ࣬ޑ pH ॶǴځణᚆηᐚࡋϷಔԋׯᡂϩ
ނᆶڰۓ࣬ޑᗖ่ૈΚǴԶቹៜቫϐှࡋϷϩނޑ่ᄬᆶфૈֹ܄Ƕ ӭኧسёऐڙ༾ለϷ༾ᡵϐᕉნǴpH ॶ 6.0-8.5ǶགྷݩϐΠǴࢬ࣬٠ό
ᆶᚆηҬඤسՉբҔǶ
4.2 ϩηᑔᒧቫݤ (size exclusion chromatography)
! ! ϩηᑔᒧቫݤǴёஒϩނ٩ϩηໆϩᚆǴ܈ѐନλϩηނ፦ǴӵᡶᜪǴၲ
ډપϯҞޑǶჹܭϩηᑔᒧቫǴ٠คڮӜǴᏉጤၸᘠቫݤ (gel filtration chromatography, GFC)ǵᏉጤᅖቫݤ (gel permeation chromatography, GPC) Ϸ ϩηᑔᒧቫݤ (size exclusion chromatography, SEC) ࣣаඔॊ࣬ӕמೌǶϩᚆ่
״ࣁനλޑϩηؑගрٰǴԶനεޑϩηၨϿΕϾࢰᡏᑈǴനӃؑගрٰǶ ϩηໆനεޑϩηคݤΕϾࢰύǴࡺനӃ೯ၸᆅࢊǴҗᆅࢊޜሜᡏᑈύࢬࢱ рٰǴջࣁᆅࢊޑ void volume (Vo)ǴԶനλޑϩη߾җᆅࢊύ܌Ԗࢬࢱనᡏᑈ Զؑගрٰ (total accessible volume, Vt)Ǵ܌Ԗᡏᑈ (Vt) ջࣁᆅࢊᗭಈѦޑᡏᑈ
(Vo) ᆶᆅࢊᗭಈϣޑᡏᑈ (Vi)ǴVt= Vo + ViǶϩނޑᅉ੮ਔ໔җؑගᡏᑈۓໆǴ
V
̛= Vo+̇
̚V
iǴViࣁЍϾࢰޑᡏᑈǹVoࣁคᅉ੮ؑගᡏᑈϐݢঢ়ǴջࣁϾࢰѦޑ ᡏᑈǶϩଛ߯ኧ (distribution coefficient)̇
̚ёჹᔈ ViޑϩѲܭϩηǶਥᏵۓကǴঁֹӄ௨ନϩηϐϩଛ߯ኧࣁ႟ǴԶϩη೯ၸ܌ԖϾࢰਔǴ
̇
̚=1ǶV̛ǵ VoǵV
i ᆶ Vtϐᜢ߯ёـკΜǴϩηޑࢬࢱຝࣣёа V̛܈̇
̚߄ҢǴӢ V̛ڗ،ܭᆅࢊЁκǴࡺϩଛ߯ኧ (
̇
̚) ၨࣁදၹҔаඔॊނ፦ޑϩᚆ܄ǶკΜǵ܌Ԗᡏᑈ (Vt)ǵᆅࢊᗭಈѦޑᡏᑈ (Vo)ǵᆅࢊᗭಈϣޑᡏᑈ (Vi) ᆶᅉ੮ ᡏᑈ(Ve)ϐᜢ߯ҢཀკǶ
Figure 10. Sketch illustrating some of the most important terms used in size exclusion chromatography(Gooding and Regnier, 1990).
4.2.1. ڰ
ڰۓ࣬! ! ٬Ҕϐጤᡏځ่ᄬࣁҬᖄ (crosslinked) ӭᗐ܈ӭ两Ǵځեᐒఓᛙۓ܄Ǵ คݤҔܭଯਏૈϩηᑔᒧቫ (HPSEC)Ǵଯਏૈϩηᑔᒧቫሡा semi-rigid organic gel Ϸ rigid silica-based stationary phase མଛޔ৩λޑጤᡏᗭಈǴᓬᗺࣁ෧Ͽ ϩਔ໔ǴځϾ৩ЁκᆶᡏᑈǴόڙډࢬࢱనׯᡂቹៜǴܭނᛙۓ܄Ϸϩਏ
ૈၨࣁᓬຫǶଯਏૈϩηᑔᒧቫጤᡏϾࢰЁκϟܭ 5-400 nm ၨத٬ҔǴࣁၲ
ډؼӳޑϩǴᒧϾ৩ЁκϷځϩѲཱུࣁख़ाǶᆶᆫӝϐጤᡏКၨǴа silica ࣁЬޑჹᓸΚϷ pH ॶၨࣁ௵གǶࣁլܺ১ᚆηҬϕբҔϷᆢᛙۓ܄Ǵsilica а diol (1,2-dihydroxy-3-propoxyprolyl bonding) অႬǴঅႬࡕጤᡏჹߎឦ਼ϯނᛙ ۓǴ٠ёऐڙ pH ॶډ 8.5ǶϾࢰᡏᑈК (Vi/Vo) ޔௗቹៜᆅࢊϐှࡋǶ
4.2.2.౽
౽࣬! ! གྷޑࢬ࣬όቹៜϩηᑔᒧسǴ٣ჴǴྋᏊϣࠅቹៜϩᚆ่݀Ǵ ቹៜϩނϷڰۓ࣬໔ޑҬϕբҔǴςவ silica-based ጤᡏளډჴǶᗖ่ܭ silica Ѩ௳தӢ steric ϐҗǴࡺ೯தϝԖॄႝޑ silanol ୷იǴ٠คঅႬԋ১҅ႝ
ޑҬඤᕉნǴԶԜᚆηҬϕբҔϐቹៜёҗׯᡂ pH ܈уΕᡶᜪፓǶ
4.2.2.1. ׯᡂ pH ॶ
! ! Silanol ූ୷ pK ॶࣁ 3.5 Կ 4Ǵࣁ১ለ୷იǴనᡏᆶϩނޑ pH ॶόӕǴ
߾ቹៜᚆη໔ҬϕբҔǴѿࢬ࣬ϐ pH ॶׯᡂǴϩނϐ pH ॶΨёૈׯᡂǶ
҅ႝޑϩނܭޑፂన (pI>pH) ύᅉ੮ܭᚆηҬඤسύǴၨႣයа
ၨଯޑ Ve (ᅉ੮ᡏᑈ) ؑගрٰǶϩނऩॄႝǴᆶॄႝޑᚆηҬඤسϕ ѾǴזೲؑගрٰǶ
4.2.2.2. ׯᡂᡶᐚࡋ
! ! ᚆη໔ҬϕբҔёᙖҗуΕύ܄ᡶᜪፓǶࢬ֖࣬Ԗଯܭ 0.6 M ޑᚆηம ࡋǴቚу౧НբҔǴԋϩނᅉ੮Ǵऩᐚࡋλܭ 0.1 M ߾ᔅշϩނϩᚆǴ
ࡺ٬Ҕϐᡶᐚࡋϟܭ 0.1 Կ 0.5 MǴԶΒሽᚆηޑᚆηமࡋࣣଯܭሽᚆη (Rogner, 1999)Ƕ
ಃ
ಃѤകǵġխࣝᔠෳБݤ
ಃġǵ୷ᘵϟಏ
! ! ϯᏢϩБݤࣁவወӧυᘋނ፦ύϩᚆǵൂᚆǴϷۓໆǵ᠘ۓБݤ (Biagini et al., 2004)Ƕа۳ޑБݤڀԖӭલᗺǴхࡴଯࡋമϷܳഢЍр (ӵ
࣬ቫ (GC)ǵన࣬ቫ (LC)ǵ፦ሺ (MS) ܈Սᖄϩ (GC-MSǵLC-tandem- MS)ǶӆޣǴϩБݤܭϩᚆપϯޑӣԏ٠όᛙۓǴ٠ӧӭݩΠౢғس
ᇤৡ(Baker et al., 2000; Barr et al., 2002; Carabias-Martınez et al., 2003)ǶϯᏢ ϩޑඹжБݤࣁխࣝϩݤǴձࢂሇનխࣝϩ (enzyme immunoassays, EIAs) Ϸሇનೱ่խࣝ֎ߕ၂ᡍ (Enzyme-linked immunosorbent assay, ELISA)Ǵதـܭᖏ
ບᘐෳໆǵᛰނᑔᒧǵᕉნҔᛰϩ(Biagini et al., 1993; Biagini et al., 1995; Biagini
et al., 2004)Ƕ
ಃΒġǵלচᆶъלচᅿᜪ
! ! २ԛ ELISA рܭ 1976 ԃǴҞჹܭғނ৮܀ᇙᏊٯӵࣅੴ (anthrax) ޑ
ෳໆςჴԖਏǶխࣝϩࣁෳۓלচϷלᡏፄӝނޑౢғǶלচࣁεϩηǴ ӵೈқ፦ǵӭᗐǵਡለǴڈᐟౢғխࣝϸᔈǴځдނ፦ӵᛰࠔǵၭᛰǴӢϩηໆ ϼλคݤൂᐱբࣁלচǴѸᆶεϩηၩᡏೱ่ (೯தࣁೈқ፦) аౢғלচ܄٠ ЇวխࣝϸᔈǴԜλϩη߾ᆀࣁъלচ (hapten)ǴӭᕉნᇙᏊ (ӵၭᛰ܈ၭᛰж ᖴނ) ࣁъלচǶҔܭբࣁъלচ-ೈқ፦Ӆ೫לচޑೈқ፦ၩᡏǴځᒧߚதख़
ा(Engvall and Perlmann, 1972; Striley et al., 1999)Ǵೱ่ܭၩᡏޑъלচኧҞϷӅ ೫ނޑϸᔈࣣቹៜלᡏޑᒃکΚǴъלচޑપࡋҭ࣬ӕख़ाǴёૈᏤठߚ౦
܄לᡏԋǶ໔႖ϩηதҔܭъלচޑᇙഢǴаቚуӅ೫ϐъלচޑלᡏ܄Ƕ לᡏᆶלচ܈ъלচᗖ่ޑૈΚҗଛᡏ (ligand) ᆶלᡏܭᗖ่Տޑ่ᄬکϯᏢ բҔ܌ڋǴלচϷלᡏ໔բҔࣁёǴЪคӅሽᗖୖᆶ(Dankwardt, 2000)ǶԜբ Ҕҗ፦ໆբҔۓࡓڋǶ
Ag+Ab=AgAb Ϸ
ൌ
ሾሿሾሿିଵ
K ࣁᒃکதኧǴAgAb ߾ࣁלচǵלᡏፄӝނǶଯᒃکதኧࣁமלচǵלᡏբҔǴ ЪܭխࣝϩύԖၨեᔠෳཱུज़ (limits of detection, LOD)Ƕ
ಃ
ಃΟġǵלᡏᅿᜪ
! ! থ٢ނޑխࣝسౢғϖᅿόӕᜪձޑלᡏǴIgAǵIgDǵIgEǵIgGǵIgMǶ խࣝౚೈқڀԖٿచ࣬ӕޑख़ (heavy chain, 50-60 kDa) ᆶᇸ (light chain, ~25 kDa)Ƕख़ᆶᇸࣣԖᒿלᡏόӕԶׯᡂ่ᄬޑᡂ౦ (VH Ϸ VL)Ǵջࣁᆶלচ ᗖ่ೀǶٿచځᎩϩᆀࣁࡡۓ (CH Ϸ CL)Ǵځữ୷ለ่ᄬᗲϿׯᡂǴԜ ׯᡂ،ۓΑᇸޑ٥ࠠ (ĸǵλ) Ϸख़ޑᅿᜪ (α, δ, γ, ε, μ)Ƕࢌ٤לᡏ߾ᙖҗࡡۓ
ᆶಒझᗖ่ǶIgG ࣁӭኧথ٢ނޑᓬ༈לᡏᅿᜪǴࢂࣁҔаว EIA ޑЬा
לᡏǴԶ ELISA ё٬Ҕൂਲ਼܈ӭਲ਼לᡏǶӭਲ਼לᡏࣁஒלচᆶᏊݙΕނ (೯ தࣁټη)ǴԏځՈమԶள(Hines et al., 2003)ǴஒϐપϯϩᚆǴౢғ܄
ӭਲ਼לᡏ(Khan et al., 2003)Ƕӭਲ਼לᡏӵځӜǴࣁխࣝౚೈқϐషӝނǴଞჹלচ
ӭᅿלচ،ۓՏ (epitope)Ƕဍዦಒझਲ਼Ϸӝԋלᡏޑ᠌ B ಒझᑼӝԋᑼӝ ዦಒझǴౢғϐלᡏڀלচ،ۓՏǴࡺᆀൂਲ਼לᡏǶൂਲ਼לᡏගٮೱុЪ ڀ܄ޑᔠෳኳԄ(Trout et al., 2004)Ƕܫխࣝϩݤ (Radioimmunoassay, RIA)
٬Ҕܫ܄ (ӵ iodine 125Ǵ125I)ǴෳۓלচϷלᡏ໔ϸᔈǶלচǵלᡏϸᔈ߄
߾٬Ҕ՚ᅦीኧෳۓ(Biagini et al., 1985)Ƕӭኧ RIA ς ELISA ڗжǴԖਔΨᙁ ᆀࣁ EIAǶ
ಃ
ಃѤġǵሇનೱ่խࣝ֎ߕ၂ᡍ (Enzyme linked immunosorbent assay)!
4.1 ڰۓ࣬ (solid phase)
! ! ELISA ࢂஒלচ܈לᡏаፂనีញࡕ༡ܭڰۓ࣬Ǵচࢂа֎ߕ (passive adsorption) ஒϸᔈނڰۓܭ߄य़ǴԜᗖ่ෳࣁ౧НբҔ
(hydrophobic interaction)ǵᓉႝЇΚ (electrostatic attraction) ϷΥቺґᅟΚ (van der Waals forces)ǶҞၨத٬Ҕ 96-well polystyrene microtiter plateǴሽեǵܰ٬ҔǴ ٠ᅌวԾϯ(Butler et al., 1992) Ƕ
4.2 ߔ༞ (blocking)
! ! ჴᡍၸำύǴԖΟᅿݩᏤठߚ܄ᗖ่Ǵϩձࢂ (1) לচǵלᡏϷ୷፦
໔ޑߚ܄ϸᔈǴ(2) ߚ܄ᚇ፦ (Ҭΰ) ԡࢉלচϷלᡏϷ (3) όܴԡࢉ
(Tsang et al., 1985b)Ƕࣁ෧Ͽߚ܄ᗖ่Ǵ٬Ҕ tris (hydroxymethyl) aminomethaneǵ ethanolamine ࣣஒೱௗՏ (binding site) ߔ༞ (blocking)ǵѐࢲϯ (inactivate)Ǵа फ़եङඳॶ(Renert et al., 1979)ǴΨёа٬ҔځдྋనӵФՈమқೈқ (bovine serum albumin , BSA)(Towbin et al., 1979; Aubertin et al., 1983)ǵfetal bovine serum(De Blas and Cherwinski, 1983; Ramirez et al., 1983)ǵhemoglobin (Gershoni and Palade, 1982)ǵgelatin(Lim and Kasamatsu, 1983)ǵTween 20(Battaiger et al., 1982; Muilerman
et al., 1982; Wedege and Svenneby, 1986)ϷФѪ(Johnson et al., 1984)Ƕ
4.3 ևՅᏊ
! ! ᔠෳس೯தࣁሇનೱ่ԿϸᔈނǴதҔޑևՅᏊԖ PNPP (p-nitrophenyl phosphate)Ǵᔠෳ alkaline phosphataseǴౢғՅНྋ܄ౢނǴෳۓ 405 nm
֎ӀॶǶABTS (2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid))ǵOPD (o-phenylenediamine dihydrochloride) ᆶ HRP (horseradish peroxidase) ϸᔈϩձౢғ ᆘՅǵՅНྋ܄ౢނǴԖ TMB (3,3',5,5'-tetramethylbenzidine) ᆶ HRP ϸᔈౢ
ғϐᙔՅނ፦ӧуΕ౷ለ܈ᕗለಖЗϸᔈࡕᙯࣁՅౢނǶᔠෳϐᡫ௵ࡋа TMB ന٫Ǵၨځдڙ፦਼ܰϯǴࡺёזೲևՅǶ
4.4 ELISA Б
БԄ! ! ELISA ёаӭᅿБԄ߄Ǵޔௗǵ໔ௗǵਂਆϷᝡݾǶޔௗ ELISA
(კΜ) ࣁ୷ҁ ELISA БԄǴஒϩނᗖ่Կ༾Ͼዬ߄य़ǴуΕჹϩނڀ
܄ᆶൔᏤسޑלᡏϷևՅᏊ٬ϐϸᔈǴғԋևՅނ፦Ƕ໔ௗ ELISA ϩݤǴ ϩނӵъלচϷלচӕኬ֎ߕԿ༾Ͼዬ߄य़Ǵ٩ׇуΕჹϩނڀ܄ᗖ่
ϐ߃ભלᡏϷჹ߃ભלᡏڀ܄ϐΒભלᡏǴᆶևՅᏊϸᔈࡕаϩӀӀࡋीෳ
ۓ֎ӀॶǴևՅໆ҅КܭᆶΒભלᡏೱ่ໆǶ
კΜǵޔௗϷ໔ௗխࣝ֎ߕ၂ᡍǶ
Figure 11. Direct and indirect immunoassay. In a direct assay (a), analyte (hapten, Ab, Ag) is bound to a solid support (i.e., bead or microplate). Reporter labeled Ab is introduced to the immobilized analyte, forming an Ag-Ab complex. After washing, the concentration of analyte is measured by radiometric, colorimetric, or fluorometric detection of the reporter system. In an indirect format (b, c), a primary Ab specific for
the analyte is introduced to the solid support bound analyte. After washing, a secondary labeled Ab, specific for the primary Ab, is added to the system. The concentration of analyte is measured by radiometric, colorimetric, or fluorometric detection of the reporter system(Biagini et al., 2006).
! ! ELISA ΨԖਂਆኳԄ (capture formate) (კΜΒ)Ǵלচਂਆ ELISA ݤ (ΞᆀΟ
ܴݯݤ)Ǵࣁלচ౦܄לᡏਂਆǴ֎ߕܭ༾Ͼዬ߄य़ǴуΕڀ܄ޑל ᡏϷևՅᏊǴ٬ҔϩӀӀࡋीෳۓځ֎ӀॶǶନԜϐѦǴᝡݾ (competitive) ELISA
߾ࢂϩނᆶϩނ໔ᝡݾᗖ่ǶϩނᐚࡋၨଯǴϩނᐚࡋၨեਔǴ ߞဦ෧১ǴԜϩБݤঅႬࡕǴࣁ blocking ELISAǴஒ҂ޑϩނӃܭ
ϩނуΕǶ
კΜΒǵਂਆϷᝡݾխࣝ֎ߕ၂ᡍǶ
Figure 12. Capture and competitive immunoassay. In an Ag capture (sometimes called sandwich) assay,Ab, specific for the analyte, is bound to a solid support. Added analyte is bound by the first specific Ab (a).After washing, another labeled Ab, specific for another epitope on the Ag, is added (b). Concentration of analyte is measured by radiometric, colorimetric, or fluorometric detection of the reporter system. In a competitive assay, analyte and a reporter labeled analyte are allowed to compete for binding sites with the immobilized antibodies (c) and bind in relation to their relative
colorimetric, or fluorometric detection of the reporter system. With
higher concentrations of analyte, less of the labeled analyte is bound yielding reduced signal(Biagini et al., 2006).
ಃ
ಃϖġǵൂਲ਼לᡏ
! ! Georges Köhler ک Cesar Milstein ܭ 1975 ԃวрᇙഢൂਲ਼לᡏמೌǶаל চխࣝλႵǴϩᚆрಒझǴஒғౢלᡏޑ B ಒझᆶମᡎዦಒझᑼӝǴౢғᑼӝ ዦಒझǴՉज़ኧีញᎦǴԋൂಒझਲ਼Ǵғԋᒣᇡלচ،ۓՏ
(epitope) ޑלᡏǴջࣁൂਲ਼לᡏ(Köhler and Milstein, 1975)Ƕ
5.1 LM2 ൂਲ਼לᡏ (anti-AGII monoclonal antibody)
! ! LM2 ࣁᒣᇡ AGII ݀ጤӭᗐ ß-linked glucuronic acid ่ᄬޑൂਲ਼לᡏǶᇙഢБ Ԅࣁஒዿԯ (Oryza sativa L. cv. Moroberekan) ಒझਲ਼ᎦనࣁלচǴԛа 100 μg མଛ٢Ꮚ (Freund’s adjuvants) խࣝεႵ (Wistar Rat)ǶࡑՈమਏሽଯਔǴڗځ᠌
ϐ B ಒझᆶମᡎዦಒझ IR983F Չಒझᑼӝࡕज़ኧีញᎦǶ٬Ҕሇનೱ่խ
ࣝ֎ߕݤ (enzyme-linked immunosorbent assayǴELISA) բࣁ߃ԛᑔᒧǴᗺᅄݤ (dot blots) ǵ Ջ Б Ꮐ ᗺ ݤ (Western blot) ᆶ ਥ Ӿ ಒ झ ϐ խ ࣝ ᑻ Ӏ ࢉ Յ Ǵ ᑔ ᒧ р LM2(Smallwood et al., 1996) Ƕ ל চ ، ۓ Տ ࣁ à-linked glucuronic acid Ǵ ࢂ arabinogalactan type II (AGII) arabinogalactan ޑڗж୷Ǵࡺ LM2 ᇡࣁᒣᇡ arabinogalactan type II (AGII) ޑלᡏǶ
5.2 LM5 ൂਲ਼לᡏ (anti-(1ʈ4)-ß-D-galactan monoclonal antibody)
! ! LM5 ࣁᒣᇡ AGI ݀ጤӭᗐ (1ʈ4)-ß-D-galactan ่ᄬޑൂਲ਼לᡏǶᇙഢБԄࣁ પϯพन (Lycopersicon esculentum cvs Ailsa Craig and Solairo) ϐಒझᏛӭᗐǴᆶ Ҙ୷ϯФՈమқೈқ (bovine serum albuminǴBSA) ᇙԋᑗೈқ (neoglycoprotein)Ǵ բࣁלচխࣝεႵ (Wistar Rat)ǴࡑՈమਏሽଯਔǴڗځ᠌ϐ B ಒझᆶମᡎዦಒ
झ IR983F Չಒझᑼӝࡕज़ኧีញᎦǶ٬Ҕሇનೱ่խࣝ֎ߕݤ (enzyme- linked immunosorbent assayǴELISA) Ϸխࣝᗺᅄݤ (immunodot-binding assay)Ǵᑔ ᒧр LM5 (Jones et al., 1997)Ƕ݀ጤύڀԖၨӭԜ่ᄬࣁ arabinogalactan type IǴ܌
а LM5 ᇡࣁᒣᇡ arabinogalactan type I (AGI) ϐלᡏǶ
5.3 LM6 ൂ
ൂਲ਼לᡏ (anti-(1ʈ5)-α-L-arabinan monoclonal antibody)! ! LM6 ࣁᒣᇡ RGI ݀ጤӭᗐϩЍ linear-(1ʈ5)-α-L-arabinan ่ᄬޑൂਲ਼לᡏǶ ஒ (1→5)-α-L-arabinoheptose ᆶ BSA ᇙԋ neoglycoprotein---Ara7-BSAǴವᅟ (mol) ೈқ፦ڀԖ 3 ঁ hepatasaccharides ჲᑗǶԛа 200 μg མଛ٢Ꮚ (Freund’s adjuvants) խࣝεႵ (Wistar Rat)ǴࡑՈమਏሽଯਔǴڗځ᠌ϐ B ಒझᆶମᡎዦ ಒझ IR983F Չಒझᑼӝࡕज़ኧีញᎦǶ٬Ҕሇનೱ่խࣝ֎ߕݤ (enzyme- linked immunosorbent assayǴELISA) Ϸխࣝᗺᅄݤ (immunodot-binding assay)Ǵᑔ ᒧр LM6 (Willats et al., 1998)Ƕ
5.4 LM7 ൂਲ਼לᡏ (anti-homogalacturonan monoclonal antibody)
! ! LM7 ࣁᒣᇡ݀ጤӭᗐ homogalacturonan ่ᄬޑൂਲ਼לᡏǶᇙഢБԄࣁа lime pectin ࣁלচǴځҘ୷✊ϯำࡋ (degree of methyl-esterification, DE) ࣁ 22.9%Ǵ ㄽữϯำࡋ (degree of amidation) ࣁ 27.3%Ǵѳ֡ϩηໆࣁ 84 kDaǶམଛ٢Ꮚ (Freund’s adjuvants) խࣝεႵ (Wistar Rat)ǴࡑՈమਏሽଯਔǴڗځ᠌ϐ B ಒझ ᆶମᡎዦಒझ IR983F Չಒझᑼӝࡕज़ኧีញᎦǶ٬Ҕሇનೱ่խࣝ֎ߕݤ (enzyme-linked immunosorbent assayǴELISA) Ϸխࣝᗺᅄݤ (immunodot-binding assay)Ǵᑔᒧр LM20(Verhertbruggen et al., 2009; Marcus et al., 2010)Ƕ
5.5 LM10 ൂਲ਼לᡏ (anti-(1ʈ4)-ß-D-xylan monoclonal antibody)
! ! LM10 ࣁ ᒣ ᇡ ݀ ጤ ӭ ᗐ AGII ϐ (1 ʈ 4)-ß-D-xylan ่ ᄬ ޑ ൂ ਲ਼ ל ᡏ Ƕ ஒ
xylopentaose (X5) ᆶ BSA ᇙԋᑗೈқ (neoglycoprotein)Ǵ٬ঁ BSA ϩηڀ Ԗ 14 ঁ xylopentaose ჲᑗǶԛа 100 μg མଛ٢Ꮚ (Freund’s adjuvants) խࣝε Ⴕ (Wistar Rat)ǴࡑՈమਏሽଯਔǴڗځ᠌ϐ B ಒझᆶମᡎዦಒझ IR983F Չ ಒ झ ᑼ ӝ ࡕ ज़ ኧ ี ញ Ꭶ Ƕ ٬ Ҕ ሇ ન ೱ ่ խ ࣝ ֎ ߕ ݤ (enzyme-linked immunosorbent assayǴELISA) Ϸխࣝᗺᅄݤ (immunodot-binding assay)Ǵᑔᒧр LM10 (McCartney et al., 2005)Ƕ
5.6 LM19 ൂ
ൂਲ਼לᡏ (anti-homogalacturonan monoclonal antibody)! ! LM19 ࣁᒣᇡ݀ጤӭᗐ homogalacturonan ่ᄬޑൂਲ਼לᡏǶᇙഢБԄࣁа apple fruitǴམଛ٢Ꮚ (Freund’s adjuvants) խࣝεႵ (Wistar Rat)ǴࡑՈమਏሽଯਔǴڗ ځ᠌ϐ B ಒझᆶମᡎዦಒझ IR983F Չಒझᑼӝࡕज़ኧีញᎦǶ٬Ҕሇનೱ
่ խ ࣝ ֎ ߕ ݤ (enzyme-linked immunosorbent assay Ǵ ELISA) Ϸ խ ࣝ ᗺ ᅄ ݤ (immunodot-binding assay)Ǵᑔᒧр LM19(Verhertbruggen et al., 2009; Marcus et al., 2010)Ƕ
5.7 LM20 ൂਲ਼לᡏ (anti-homogalacturonan monoclonal antibody)
! ! LM20 ࣁᒣᇡ݀ጤӭᗐ homogalacturonan ่ᄬޑൂਲ਼לᡏǶᇙഢБԄࣁа
Arabidopsis thaliana ޑ
ᅿηᗹన (seed mucilage) ࣁלচǴམଛ٢Ꮚ (Freund’s adjuvants) խࣝεႵ (Wistar Rat)ǴࡑՈమਏሽଯਔǴڗځ᠌ϐ B ಒझᆶମᡎዦ ಒझ IR983F Չಒझᑼӝࡕज़ኧีញᎦǶ٬Ҕሇનೱ่խࣝ֎ߕݤ (enzyme- linked immunosorbent assayǴELISA) Ϸխࣝᗺᅄݤ (immunodot-binding assay)Ǵᑔ ᒧр LM20(Verhertbruggen et al., 2009; Marcus et al., 2010)Ƕ5.8 JIM7 ൂਲ਼לᡏ (anti-homogalacturonan monoclonal antibody)
! ! JIM7 ࣁᒣᇡ݀ጤӭᗐ homogalacturonan ่ᄬޑൂਲ਼לᡏǶᇙഢБԄࣁа Carrot
(Daucus carota L. cv. Early Nantes) ᅿηࣁלচǴམଛ٢Ꮚ (Freund’s adjuvants) խࣝεႵ (Wistar Rat)ǴࡑՈమਏሽଯਔǴڗځ᠌ϐ B ಒझᆶମᡎዦಒझ IR983F
Չ ಒ झ ᑼ ӝ ࡕ ज़ ኧ ี ញ Ꭶ Ƕ ٬ Ҕ ሇ ન ೱ ่ խ ࣝ ֎ ߕ ݤ (enzyme-linked immunosorbent assayǴELISA) Ϸխࣝᗺᅄݤ (immunodot-binding assay)Ǵᑔᒧр JIM7(Knox et al., 1990; Willats et al., 2000; Clausen et al., 2003)Ƕ
5.9 ൂ
ൂਲ਼לᡏᆶނಒझᏛӭᗐᒃکϸᔈϐᔈҔ! ! ᒣᇡۓಒझ߄य़ᗐᜪלচ،ۓՏ (epitope) ޑൂਲ਼לᡏ (MAbs) ࣁӭф
ૈϩηଞǴҔܭނಒझǵϩηғނϷಔᙃวǶ1970 ԃ२ԛаણᏛϷᝯӭ ᗐࣁჹຝࣴزځխࣝۓՏ(immunolocalization)(Knox et al., 1970; Vreeland, 1970)Ǵ٠ Ъаൂਲ਼לᡏՉނխࣝಒझϯᏢϷણޑלচϷၸ௵চࣴز (Knox et al., 1980)Ǵӧ 1980 ԃ໒ۈᜢܭۓಒझϐӭᗐלՈమࣴز(Moore et al., 1986; Cassab and Varner, 1987; Stafstrom and Staehelin, 1988; Ryser and Keller, 1992; Condit, 1993;
Swords and Staehelin, 1993)Ǵൂਲ਼לᡏࣁԖΚπڀǴගٮނಒझ่ᄬǵಔᙃϷ фૈၗૻǴӵಒझᏛᆶझѦ୷፦ޑಔᙃϷ่ᄬǵКၨόӕಒझ໔วػৡ౦ǵዴۓಒ झᏛᜢܭᒪӭኬ܄ޑϩηৡ౦ǵෳಒझᏛ܈ᆫӝނޑלচ،ۓՏϐфૈǴ٠ ڀԖᐱޑᓬ༈ӵۓ܄ (monospecificity)Ǵᒣᇡ҂પϯϐނڗނձԖ Ҕ(Anderson et al., 1984)Ƕۓ܄ჹܭᗐೈқϷӭᗐཱུࣁख़ाǴӢࣁ೭ᜪלচ ೯தୖᚇځдלচ،ۓՏǴࡺሡाۓޑӭਲ਼לՈమપϯϐǶނಒझ߄य़ ڀԖӭኬϯಒझୱ (domains)Ǵх֖ಒझጢϷಒझᏛǴගٮಒझวфૈ(Roberts, 1989; 1990)ǴҞൂਲ਼לᡏҔܭӭϩБय़ӵᗖ่ǵғϯ܄ᆶނಒझ߄य़ޑ วፓǵຑಒझጢપϯำࡋǵচғ፦ᡏ܄ (protoplast properties)ǵ᠘ۓಒझ ߄य़ಔԋϷܭಔᙃکಒझޑϩѲኳԄǴԖճܭᔠෳϩϯלচǶ
! ! аൂᗐ܈ჲᗐᝡݾൂਲ਼לᡏ-לচޑ ELISA ᔠෳҭёࡰрۓޑלচ،ۓՏ
(Pennell et al., 1989; Pennell et al., 1991)Ǵջ٬ъלচ٠คᡉҢҺՖԖᜢלচ่
ᄬǴҭёவխࣝೱ่ύளޕځᄬࠠϷ࣬ᜢಔԋ (კΜΟ) (Pennell et al., 1989)Ƕ
კΜΟǵൂਲ਼לᡏᒣᇡלচ،ۓՏ (epitope) ෳӭᗐ่ᄬǶ
Figure 13. Monosaccharide components of carbohydrate epitopes. The binding
inhibition was determined by ELISA. The inhibition by gum arabic (a), an AGP, shows that MAC 207 and JIM8 recognize AGP epitopes. Further, the different patterns of inhibition by hapten monosaccharides (a) show that the MAC 207 and JIM8 epitopes are different, and that the MAC 207-reactive epitope probably contains arabinose and glucuronic acid. Chemical analysis of AGP carbohydrates suggests that the arabinose is a terminal, so it is likely that the MAC 207-reactive epitope is terminal as well (b). The composition of the JIM8 epitope is unknown but, as shown in (b), it is probably
subterminal. The AGP backbone is composed of 1,6-linked galactosyl residues. The numbers in the table refer to the inhibitor concentration required for 50% diminution in ELISA signal (Iso).
! ! Arabinogalactan-protein ࣁೈқӭᗐǴϩѲܭނಔᙃǴڀԖխࣝᡉ܄
(immunodominant)ǴࣁЬाౢғխࣝϸᔈޑނ่ᄬ(Anderson et al., 1984; Norman
et al., 1986; Evans et al., 1988; Knox et al., 1989; Pennell et al., 1989; Norman et al.,
1990; Knox et al., 1991)Ǵҗ Anti-AGP ൂਲ਼לᡏᡉҢځ߄ቶݱޑวػፓᐒڋǶൂਲ਼לᡏςᑔᒧىаܢלނಒझጢ ATPase(Chin, 1982)ǵڋғߏન (auxin) ޑཱུ܄ၮᒡ (polar transport)(Jacobs and Gilbert, 1983) Ϸጋણቫচғ፦ᡏύ㱏ပለ
(abscisic acid) ϸ ᔈ Ƕ ӭ ᅿ ಒ झ Ꮫ ᆫ ӝ ނ ޑ ל Ո మ ܢ ל Ӛ ᅿ س ύ ᇨ Ꮴ ՜ ߏ (elongation) ޑ ғ ߏ ન Ǵ ӵ ҏ ԯ ख ᓋ (maize coleoptiles) ޑ ל ဟ ᆫ ᑗ 䁙 (antiglucanase)ǵᆘلखື (bean epicotyls) ޑלЕᆫᑗ䁙 (antixyloglucan)ǴϷᡳ
ل (chickpea) ޑל ß ъ٢ᑗ䁙 (anti-ß-galactosidase)(Hoson et al., 1991; Inouhe and Nevins, 1991; Hoson et al., 1992; Valero and Labrador, 1993)ǶᒿଯᒃکΚଞ Ϸख़ಔ DNA ޑמೌୢШǴಒझᏛӭᗐϷᗐೈқޑלচ،ۓՏᅌዴҥǶ
! ! ݀ጤࣁፄᚇӭᗐǴԖӭᅿ่ᄬୱ (domain)Ǵх֖ acidic homogalacturonanǵ rhamnogalacturonan Ϸύ܄ᗐЍ(O'Neill et al., 1990)Ǵځфૈࣁύጤቫಒझᗹǵ
ڋ߃ભಒझᏛᚆηރᄊϷϾሜǵቹៜሇનϷځдᆫӝނբҔǴԶ݀ጤӭᗐТࢤ
߾ڀٛᑇᐒڋǶᙖҗ݀ጤϐխࣝۓՏวלᡏଞ (antibody probe)ǴЬाҔܭխ
ࣝᑻӀ (immunofluorescence) Ϸխࣝߎ (immunogold) ࣴزǶ݀ጤלᡏჹܭಒझϩ ϯԖӭᅿᔠෳБݤǴҔܭಒझǵᎦ୷س(Van Engelen et al., 1991; Stephenson and Hawes, 1994; David et al., 1995; Stacey et al., 1995)ǴԜѦϝԖխࣝᒃکמೌ่
ӝॄࢉႝηᡉ༾᜔ᔠෳ(McCann et al., 1992)ǶᡏٰᇥǴၮҔ݀ጤלᡏёа߄ό ӕಒझᅿᜪǵಔᙃǵᏔ۔ǵᅿᜪύ݀ጤ✊ϯޑׯᡂǴᆶ݀ጤלᡏೱௗᆶցǴ٠όж ߄݀ጤрԖคǴҗלচ،ۓՏёаளޕಒझᏛࢂցڀԖঅႬ୷ǴҞ٬Ҕς ۓက (defined) ଞෳۓҘ୷✊ϯТࢤǵrhamnogalacturonan ମࢎޑۓჲᑗׇӈ Ϸ arabinogalactan ЍǶלᡏଞჹܭ݀ጤ่ᄬှཱུࣁख़ाǴёޕځԋߏวػޑ ቹៜୖኧǶғԋӭᗐלᡏޑख़ा٩ᏵࣁൂᗐϷჲᑗ ᆶೈқ፦ጠӝԋխࣝচ (immunogen)Ǵ٣ჴࢌ٤ӭᗐ٬Ҕ࣬ӕޑಔԋӵൂᗐϷᗖ่ቻǴԶ೭ᜪޑלՈ మ٠όڀ܄ǴᖐٯٰᇥǴ٬Ҕα-L-arabinofuranoside-arninophenyl protein բࣁ לচౢғޑלᡏёаᒣᇡ arabinoxylan Ϸ arabinogalactan(Kaku et al., 1986; Misaki
et al., 1988)ǴԜБݤςҔܭౢғӵԛભಒझᏛύޑ xylanǵلᜪಒझ݈ޑ callose
Ϸ arabinogalactan ϐۓלՈమ(Northcote et al., 1989)ǶӭኧՏܭނಒझᏛޑೈқ፦όڀሇનࢲ܄ǴගٮಒझᏛ่ᄬբҔ(Showalter, 1993)Ƕ
! ! Arabinogalactan-protein ቶݱӸӧނύǴୖᆶಒझวػၸำǶAGP לᡏЬा
ᒣᇡҗ arabinogalactan ಔԋϐלচ،ۓՏǴຎࣁނύගٮխࣝϸᔈޑЬाՏ
ǶКၨᝌੌᎦޑዿԯಒझϷचᡀጱಒझਲ਼ǴϩᚆዿԯύۓϷߚۓ AGP ൂ ਲ਼לᡏǶLM2 ࢂҗዿԯౢғϐൂਲ਼לᡏǴӧۓᎦ୷ύǴLM2 ᆶٿᅿ AGP ڀᒃ کϸᔈǴࠅѝᆶचᡀጱϐᅿ AGP ౢғᒃکϸᔈǶAGP ќख़ाቻᆶಒझጢ࣬
ᜢǴಒझጢᆶНྋ܄झѦ AGP ϐ࣬ᜢ܄ё٬Ҕ LM2 ٰղۓǴᡉҢዿԯಒझጢ
AGP ࣁ౧Н܄ǴԶचᡀጱϐ AGP ߾ࣁᒃН܄(Smallwood et al., 1996)Ƕ
! ! ނಒझᏛ่ᄬςᅌҗࣴزளޕǴಒझᏛޑϩηୱ (molecular domain) ϷಒझϩϯԋಒझᏛǵಒझጢ໔ϐৡ౦Ƕלᡏჹܭނ߄य़ޑှගٮཱུεޑଅ
Ǵ߈ԃٰלᡏޑว׳җಒझᘉεډ୷ӢቫભǶϞמೌёᙖҗڋ DNA ჹᔈ ϐጓዸלᡏ่ӝՏǴीᑔᒧϩηଞǴቚу٬Ҕܭނಒझ߄य़ϐёૈ܄ǶҞ
ϝሡளޕಒझᏛޑࡌҥᐒڋǵಔԋϷࢎᄬǶӭᅿଞჹଯǵեނಒझᏛಔԋޑ
ൂਲ਼לᡏቶݱҔܭᒣނᅿϷځسǴٯӵଯۓက܄ଞǴх֖ 5 Կ 7 ঁൂᗐޑ neoglycoproteinǶ
! ! ൂਲ਼לᡏ҂ٰයఈૈᔈҔܭᄊسǴӵಒझޑ่ᄬፓǵϸᔈғނวϷુ
ॐϐૻ৲ǴܭϩᜪፓගٮނಒझᏛϩϯว׳ቨᗡޑຎഁ(Knox, 1997)Ƕ
ୖ
ୖǵġ၂ᡍࢬำკ
α-amylase amyloglucosidase
Crude polysaccharides
Water-soluble nondigestible polysaccharide
Digestible polysaccharide (1,4;1,6-α-D-glucan)
Anion exchange chromatography
F1.F2.F3.F4
Immunoaffinity
l l
Size exclusion chromatography
စ
စǵġᆶБݤ
ಃകǵġჴᡍ
ಃǵġՋࢩୖኬࠔ
1.1 ٰྍ
! ! ଳᔿՋࢩୖҗ୯ϣ१ࠔϦљගٮǴаણ࿗ᐒ (RT-08Ǵٿးણ࿗ᐒǴ22000 rpm)Ǵ
Չϖԛણ࿗Ǵԛણ࿗ុ 3 ࣾǴણ҃ᓯӸܭٛዊጃǶ
1.2 Нڗނϐᇙഢ
! ! ڗՋࢩୖણ҃ 50²0.1 gǴуΕ 750 mL ΒԛᇃᚖНǴܭ 100ɗݦНڗ 3 λਔǴаଯೲᚆЈᐒ (Beckman coulter) 8000 rpm (11325 g) ϐᙯೲᚆЈ 15 ϩដǴ ஒڗనа Whatman NO.54 ᘠરၸᘠǶ؈ᐘނа 350 mL ΒԛᇃᚖНǴܭ 100ɗݦ Нڗ 30 ϩដǴख़ፄڗᡯǴӆஒ؈ᐘނуΕ 350 mL ΒԛᇃᚖНǴܭ 100ɗ ݦНڗ 30 ϩដǴԏΟԛ܌ளϐᘠనǴᐚᕭۓԿ 1000 mLǴջࣁНڗ ނ (hot- water extract)Ƕ
1.3 Нྋ܄ಉӭᗐϐᇙഢ
! ! ஒॊᇙഢϐНڗނ (1000 mL)ǴуΕ 4 ७ଚᆒ؈फ़Ǵᓉ႖ڹ܌ளϐӭ ᗐ؈ᐘނࣁНྋ܄ಉӭᗐ (crude polysaccharides)Ƕ
1.4 Нྋ܄ёϯӭᗐϷόёϯӭᗐϐᇙഢ
! ! ڗໆಉӭᗐଚᆒᝌੌనǴᚆЈѐନమଚᆒǴख़ፄаଚᆒమࢱኧԛǴаΒԛ ᇃᚖНൺྋಉӭᗐ؈ᐘނǴ٠ܭ 100ɗݦНΠྋှ 2 λਔǴྋనհࠅࡕۓ Կ 100 mLǴෳۓᅹНϯӝނ֖ໆ (ऊ 1 g)Ƕа 1 g ᅹНϯӝނࣁٯǴஒྋన pH ॶፓ
Կ 6.0ǴуΕ 100 μL ऐ܄ α-amylaseǴܭ 95ɗНύϸᔈ 30 ϩដǴհࠅԿ࠻
ྕǴஒྋన pH ॶፓԿ 7.5²0.1ǹуΕ 500 μL proteaseǴܭ 60ɗНύϸᔈ 30 ϩ
ដǴհࠅԿ࠻ྕǴஒྋన pH ॶፓԿ 4.5²0.2ǹуΕ 100 μL amyloglucosidaseǴܭ 60ɗНύϸᔈ 30 ϩដǴհࠅԿ࠻ྕǴۓԿ 100 mLǴуΕ 4 ७ᡏᑈ (400 mL) 95%ଚᆒǴᓉ႖ڹ٬ӭᗐϩη؈फ़Ƕ႖ВаᚆЈБԄڗమଚᆒǴՉᐚᕭѐନ ଚᆒǴࣁНྋ܄ёϯӭᗐ (digestible water-soluble polysaccharides)Ƕ؈ᐘނа
ໆ 78%ଚᆒྋనᝌੌϩණǴమࢱ؈ᐘނ߄य़ϐλϩηǴԜమࢱᡯख़ፄ 2-3 ԛǴ؈
ᐘނջࣁНྋ܄όёϯӭᗐ (water-soluble nondigestible polysaccharides)Ƕ
1.5
ᚆηҬඤᐋિቫϐНྋ܄όёϯӭᗐϩڗᕴᗐໆऊ 10 mg ϐНྋ܄όёϯӭᗐଚᆒᝌੌనǴᚆЈѐନమଚᆒǴ ख़ፄаଚᆒమࢱኧԛǴаΒԛᇃᚖНൺྋӭᗐ؈ᐘނǴᚆЈڗளమϐӭᗐྋనǴ
Whatman NO.54 ᘠરၸᘠǴݙΕᚆηቫᆅࢊ (XK 26/40 Series, 300Ø26 mm i.d., GE health, Uppsala, Sweden)Ǵ༤кϐጤᡏࣁ Toyopearl DEAE-650M (Tosho, Tokyo, Japan)Ǵа 20 mM Tris མଛ 0 Mǵ0.1 Mǵ0.18 M ᆶ 0.3 M NaCl ϐࢬࢱనǴ аϩដ 0.8 mL ϐࢬೲՉఊࡋؑගǴளډόӕႝமࡋϐӭᗐϩǴԏӚ
ϩǴ෧ᓸᐚᕭࡕа 4 ७ᡏᑈଚᆒ؇फ़ԏӚϩϐӭᗐǶ
ಃ
ಃΒǵġჴᡍᛰࠔᆶ၂Ꮚ 2.1 ϯᏢᛰࠔᆶ၂Ꮚ
Acetic acid, AcOH, CH3COOH ᖼԾ Merck, Darmstadt. Germany.
Acetic anhydride, AC2O, (CH3CH2)2O ᖼԾ Sigma-Aldrich, St. Louis, U.S.A.
Acetone, CH3COCH3ᖼԾ Sigma-Aldrich, St. Louis, U.S.A.
Anhydrous methanol, CH3OH (99.8%) ᖼԾ J.T.Baker, Philipsburg, NJ, U.S.A.
Barium acetate, (CH3COO)2Ba ᖼԾ Showa, Tokyo, Japan.
Bio-Rad protein assay dye concentrate ᖼԾ Bio-Rad, Hercules, CA, U,S,A.
Ethanol, C2H5OH (95%) ᖼԾ Echo Chemical, Taipei, Taiwan.
Hydrocholoric acidm HCl (37%) ᖼԾ Sigma-Aldrich, St. Louis, U.S.A.
m-hydroxydiphenyl (3-phenyl phenol)ᖼԾ Aldrich, Bothell, WA, U.S.A.
Phenol, C6H5OH ᖼԾ Wako Pure Chemical, Osaka, Japan.
Potassium chloride, KCl ᖼԾ Merck, Darmstadt. Germany.
Potassium dihydrogen phosphate, KH2PO4ᖼԾکӀપᛰ, Tokyo, Japan.
Sulfuric acid, H2SO4(95-97%)ᖼԾ Sigma-Aldrich, St. Louis, U.S.A.
Sodium azide, NaN3ᖼԾ Sigma-Aldrich, St. Louis, U.S.A.
Sodium chloride, NaCl ᖼԾ J. T. Baker, Philipsburg, NJ, U.S.A.
Sodium hydroxide, NaOH (50%, v/vǴϩભ)ᖼԾ Mallinckrodt Baker, Philipsburg, NJ, U.S.A.
Sodium nitrate, NaNO3ᖼԾ J. T. Baker, Philipsburg, NJ, U.S.A.
Sodium phosphate, NaHPO4 ᖼԾکӀપᛰ, Tokyo, Japan.
Sodium tetraborate, Na2B4O7Ǹ10H2O ᖼԾ Wako Pure Chemical, Osaka, Japan.
Trifluoroacetic acid, TFA, CF3CO2H ᖼԾ Fisher Scientific, Fair Lawn, NJ, U.S.A.
Tris (Base) ᖼԾ J. T. Baker, Philipsburg, NJ, U.S.A.
2.2
ྗࠔ! ! L-arabinose, D-fucose, D-galactose, D-galacturonic acid, D-glucose, D-glucuronic acid, D-mannose, L-rhamnose, sorbitol, D-xylose, blue dextranǵbovine serum albumin (BSA)ǵcitrus pectinǵgum arabicǵ4-O-methyl-glucuronoxylan ྗࠔࣣᖼԾ Sigma, St. Louis, MO, U.S.A.ǹ(1ʈ5)-α-L-arabinan ᖼԾ Megazyme, Wicklow, Ireland.ǹ pullulans ྗࠔᖼԾ Showa Denko, Tokyo, Japan.
2.3 לᡏ
! ! LM2 (monoclonal antibody to arabinogalactan-protein)ǵLM5 (monoclonal antibody to (1ʈ4)-ß-Galactan)ǵLM6 (monoclonal antibody to (1ʈ5)-α-L-arabinan)ǵLM10 (monoclonal antibody to (1 ʈ 4)-ß-D-xylan) ǵ LM19 (monoclonal antibody to homogalacturonan) ǵ LM20 (monoclonal antibody to homogalacturonan) ǵ JIM7 (monoclonal antibody to homogalacturonan) ࣣᖼԾ Plantprobes, Leeds, UKǶ
2.4 ሇન
! ! Amyloglucosidase (3200 U/mL)ǵheat-stable α-amylase (3000 U/mL)ǵprotease (50 mg/mL)ǵglucose diagnostics (115-A) ࣣᖼԾ Sigma, St. Louis, MO, U.S.A.Ƕ
2.5 ᕗለፂన (phosphate buffer) ଛᇙ 2.5.1. ᕗለፂనଛᇙ
! ! ᕗለፂనࣁ 0.002 M KH2PO4(0.24 g/L)ǵ0.14 M NaCl (8 g/L)ǵ0.003 M KCl (0.2 g/L)ǵ0.01M Na2HPO4(1.44 g/L)ǴpH ॶࣁ 7.4Ƕ
2.5.2. όӕ pH ॶϐᕗለፂనଛᇙ
! ! όӕ pH ॶϐᕗለፂనࣁ 0.002 M KH2PO4(0.24 g/L)ǵ0.14 M NaCl (8 g/L)ǵ